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ABSTRACT
Nanotechnology is a multidisciplinary field that combines science and 
engineering to design, synthesize, characterize and explore applications for materials and 
devices whose smallest functional organization in at least one dimension is on the 
nanometer scale. Nanotechnology is undergoing an explosive development and the extent 
of potential application is vast and widely diverse. In the field of human health care, 
nanotechnology is helping to develop novel materials and structures, which have made it 
possible to miniaturize many of the tools used in conventional assays. Smart biochips 
constructed out o f these novel materials and structures are now capable o f performing 
limited in vitro diagnostic tests involved in immunoassays. In this work, we report two 
devices that make use of micro scale and/or nano scale structures to contribute to the 
ever-expanding use o f biochips in human health care.
The first device is a Patch-Clamp microchip that is capable o f monitoring cell 
viability in real-time. It is critical to monitor the health of cells in biological life science 
and medical research. Researchers must know if a new drug is capable of killing cancer 
cells or in other cases to determine the toxic effects of a drug or a pesticide on healthy 
cells. Conventional cell viability monitoring techniques that use flow cytometer or 
fluorescent dyes in conjunction with fluorescence microscope are time consuming and 
require sample labeling. Alternatively, we have designed a patch-clamp microchip, which 
allows one to measure the ion-channel currents in real-time. This microchip provides a
faster and label-free platform to monitor the health of the cell. Simultaneously, viability 
tests were performed on four different types o f cancer cells (MB231, MB231-BR-vector, 
MB231-BR-HER 2, and MB231-BR) using the conventional fluorescent dye technique 
and using the patch-clamp microchip technique. For the patch-clamp technique, the seal 
resistance o f the device decreased from ~22 MQ (living cell) to ~4 MQ (dead cell) over a 
period o f 120 minutes. Comparing the seal resistance to the intensity o f the fluorescence 
images over the 120 minute period confirms a correlation between the health o f the cell 
and the ion-channel current, validating our claim that the patch-clamp microchip can be 
used as an alternate technical platform to the conventional techniques that use fluorescent 
dyes or a flow cytometer.
The second device is a Field-Effect Transistor (FET) based biosensor used for the 
detection of biomolecules. The conventional technique, ELISA, is still the gold standard 
for immunoassays. Most of the modem biosensors have exploited the semi conductive 
nature o f CNT to design a label-free FET based immunosensor (biosensor that 
exclusively monitors the antibody-antigen interaction). Even though biosensors made out 
of a single CNT are ideally capable of detecting a single molecule, the fabrication of such 
devices is challenging. To avoid the fabrication complexity involved with a single CNT 
based immunosensor, we have developed an FET based biosensor, in which the channel 
is made out of Carbon Nanotube Thin Film (CNTF). The CNTF channel between the 
source and drain electrodes is assembled using electrostatic layer-by-layer (LBL) self- 
assembly. The bio-affinity interaction between Protein A and rabbit IgG is used to model 
the antibody-antigen interaction, and our initial results show the device is capable of 
detecting IgG concentrations as low as 1 pg/mL.
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CHAPTER 1
PATCH-CLAMP MICROCHIP: INTRODUCTION
In biological life science and medical research, it is critical to distinguish between 
living and dead cells. Specifically, it is important to know if a potential cancer treatment 
drug has killed the cancerous cells. In order to monitor the cells’ viability, the 
colorimetric or fluorescence technique is usually used [1]—[3]. Typically, these methods 
require a flow cytometer or the labeling of cells with fluorescent dyes in conjunction with 
using a fluorescence microscope to evaluate viability, making them time-inefficient 
and/or cost-ineffective. In addition, these techniques are not convenient for studying the 
dynamic process of cell death in real-time. For instance, the fluorescence images of the 
cells have to be processed with image processing tools, which can sometimes render the 
real-time monitoring unfeasible.
Recently, a technique measuring volume changes in single cells using a 
microfluidic chip has shown great promise for real time monitoring o f treatment drug on 
the cells’ viability [4]—[6]. This type of biosensor utilizes an electrical impedance method 
to monitor the volume change of a cell. Specifically, the cells to be measured are sent 
through a micro-chamber via a microfluidic network. When their volumes change, the 
extra-cellular fluid in the micro-chamber will be pushed out. As a result, the electrical 
resistance o f the chamber will change. Using this microfluidic chip, high throughput drug
1
screening can be achieved. Therefore, a tagless technique, which offers instantaneous and 
quantitative information about cell viability, becomes very attractive.
Traditional PC technology is very time consuming and requires laborious effort 
with a rather low throughput. For the past decade, various types of PC microchips have 
been developed in several groups to enhance the throughput and efficiency over the 
conventional glass-pipette based PC technology [7]—[11 ]. It has been demonstrated that 
by using a properly designed and fabricated micropipette, some PC microchips show 
reliable and consistent Gigaseal (resistance in the range of giga ohms) capability, 
indicating the possibility that the PC microchip can eventually replace the conventional 
glass-pipette PC technology.
In this work, we offer an alternate viable technical platform for monitoring cell 
viability in real time using a planar patch-clamp microchip [12] .
1.1 Key Accomplishments of the Project
The significant accomplishments of this project include fabrication of the planar 
patch-clamp microchip, successful recording of ion-channel currents in four different 
types of human breast cancer cells including MDA-MB231, MDA- MB231-brain 
metastatic subline (abbreviated as MB231 -BR), MB231 -BR over-expressing HER2 gene 
(MB231-BR-HER2), and MB231-BR-vector control for the HER2 (MB231-BR-vector), 
and simultaneously validating the results against the change in cell fluorescence intensity 
to prove the viability of the patch-clamp microchip technical platform. It has been 
demonstrated that, even though the seal resistance of the PC microchip is in the range of 
Mega-ohms (MQ), it is still able to monitor cell viability.
31.2 Outline of the Patch-clamp Microchip Project
In CHAPTER 2 we begin with a discussion on ion-channels, the gating 
mechanisms in ion-channels, the ion-channel assays and use o f patch-clamp technique in 
these assays. We then explain the basic construction of a patch-clamp device and the 
various configurations it can be employed. The chapter ends with a discussion on the 
planar patch-clamp structure, its significance, cell viability and how the planar patch- 
clamp structure can be used as a technical platform to monitor cell viability.
In CHAPTER 3 we discuss the various components of the microchip. The design 
aspect of each component including the micropipette, which is the most vital part o f the 
microchip, is explained with different schematics. The chapter concludes with a mention 
of the various materials and equipment that are required to fabricate the microchip.
A detailed fabrication process for each component o f the microchip is discussed 
in CHAPTER 4.
CHAPTER 5 discusses the build up to the real-time viability monitoring 
experiments by introducing the experimental setup and the protocol used.
In CHAPTER 6 we discuss the performance of the patch-clamp microchip. The 
ion-channel currents for 12 cells from 4 different cell lines are recorded over a period of 
time and simultaneously fluorescence images o f the cell are also recorded. The validity of 
the patch-clamp microchip as a viable technical platform for real-time monitoring of cell 
viability is discussed after comparing the change in seal resistance and the change in 
intensity o f the fluorescence images.
In CHAPTER 7 we summarize the patch-clamp microchip project and discuss its 
future direction.
CHAPTER 2
PATCH-CLAMP MICROCHIP: RESEARCH BACKGROUND
2.1 Ion-channels
The structure of a Eukaryotic cell is shown in Figure 2-1. The external membrane 
of the cell, called the plasma membrane or cell membrane, plays a crucial role in 
maintaining the balance between the intracellular and extracellular environment.
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Figure 2-1: Structure o f a Eukaryotic cell [13].
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5The cell membrane is made up of phospholipids and protein molecules, which are 
held together by non-covalent interactions. Specialized trans membrane proteins create 
pore like structures on the membrane called ion-channels as shown in Figure 2-2.
Figure 2-2: Cell membrane with an Ion-Channel [4].
Gating is the process of opening and closing the ion channel; this process 
facilitates the transport of ions like Na+, K+, Ca+ or Cl' between the cell and the 
surrounding environment. In 1952, Hodgkin and Huxley established that the movement 
o f Na+ and K+ in a giant nerve fiber contributed to ionic currents [14]. Hodgkin and 
Huxley also established that there were independent ionic pathways for Na+ and K+ flow. 
The definite existence of ion-channels was only demonstrated later, in 1972, by Hladky 
and Hayden [15]. Hladky and Hayden studied the change in conductance induced by an 
antibiotic gramicidin A. They also observed these channels were permeable to univalent 
cations, but completely impermeable to polyvalent anions and cations.
Ion-channels are classified depending on the type of ion they transport. The 
prominent channels are sodium channels, potassium channels, calcium channel, and 
chloride channels. The ion-channels open and close in response to a stimulus, the
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stimulus could be a change in membrane potential or binding of a ligand (chemical 
messenger). Depending on the stimulus, ion-channels can be classified into three broad 
categories: voltage-gated channels, extracellular ligand-gated and intracellular ligand- 
gated as shown in Figure 2-3. The difference in ion concentration between the 
intracellular medium (cytoplasm) and the extracellular medium builds up a potential 
across the cell membrane; this is called the resting membrane potential. Voltage-gated 
channels conduct when there is a change in the membrane potential. Extracellular ligand- 
gated channels conduct in response to ligand molecules binding to the extracellular 
domain. Intracellular ligand-gate channels conduct in response to ligand molecules 
binding to the intercellular domain.
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Figure 2-3: Types o f ion-channel gating mechanisms [16].
Many diseases have been linked to ion-channels [17]. These diseases are usually 
caused due to the mutation of genes in the ion-channels. Research has shown that 
mutations in voltage gated Ca2+ channel genes result in migraine headache and some 
forms of epilepsy, while others like long QT syndrome are caused due to the mutation of 
genes in either Na+ or K+ channels. Many o f these inherited ion channel diseases caused
7due to mutation in Na+, K+, Ca2+ and Cl' channels are collectively called channelopathies 
[18].
2.2 Drug Discovery
The process of identifying a chemical compound (drug) that has a therapeutic 
effect is tedious and complicated. To find the cure to a disease, it is important first to 
understand the disease and the conditions that cause it. Understanding the disease 
involves understanding how the genes are affected, how the genes affect the proteins they 
encode, how those proteins interact with each other in living cells, how those affected 
cells change the specific tissue they are in, and finally how the disease affects the entire 
patient’s health. Modem drug-discovery chain can be divided into five basic segments. 
They are: target identification and validation, primary screening, secondary screening, 
safety screening, and preclinical testing [19].
2.2.1 Target Identification and Validation
Once the underlying cause of the disease is understood, a target is selected. The 
target is a single molecule, either a gene or a protein, which is involved in the disease.
The selection is such that the target can potentially interact and be affected by a drug 
molecule. It is important to validate the relevance of the target to the disease. It is 
possible that the target shows a lot o f promise to begin with, but it could eventually lead 
to a dead end.
2.2.2 Primary Screening
There are thousands of molecules known to pharmaceutical companies today. 
Primary screening involves exposing the target to different molecules. A specific 
modulation is expected to occur in the target upon exposure to these molecules. The
8screening data is then examined to find the molecules that cause the desired modulation; 
these molecules are identified as lead compounds.
2.2.3 Secondary Screening
Primary screening helps construct focused libraries, which are then optimized 
during the secondary screening. For example, the structure o f a molecule can be changed 
in a way such that it does not react with any other chemical pathways in the body, thus 
reducing the potential for side effects.
2.2.4 Safety Screening
Every lead compound is tested for safety. These tests target the pharmacokinetics, 
or absorption, distribution, metabolism, excretion, and toxicological properties of the 
lead.
2.2.5 Preclinical Testing
This stage involves a large number o f in vitro and in vivo tests to narrow down the 
candidate drugs, which will be studied in the clinical trials. In vitro tests are conducted in 
the lab and carried out in beakers and test tubes. In vivo tests are conducted on animal 
models and living cells. The data from these tests shows the efficacy o f the drug and its 
safety profile.
2.3 Ion-channel Assays 
The process to find candidate drugs that can cure an ion-channel related disease is 
the same as discussed in Section 1.2. There are several types of popular standard ion- 
channel assay technologies, and new emerging technologies have been reported every 
year. The most popular ion-channel assay technologies are: Patch-clamping, 
Fluorescence-based methods, Flux assays, and Binding assays [20].
92.3.1 Patch-clamping
The patch-clamp technique involves placing a pipette (tip o f the pipette is a few 
microns in diameter) with electrolytic solution against the cell membrane of a living cell 
and applying a small amount of suction. This suction forms a tight electrical seal between 
the cell membrane and the pipette usually in the order o f giga-ohms. An Ag/AgCl 
electrode is then inserted into the pipette such that it makes contact with the electrolyte in 
the pipette. The ionic current between the electrolyte and the cell is sensed by this 
electrode and fed to an amplifier, which analyzes the conductance and kinetics associated 
with the ion-channels. A simple patch-clamp configuration is shown in Figure 2-4. The 
patch-clamp technique proves to be a great tool with high potential in the research of 
neuroscience and electrophysiology for its ability to measure functions directly like 
gating, permeability, voltage sensing, and selectivity of ion-channels.
Electrode
Micropipette
Cell Membrane Na+ channel
Figure 2-4: Simple patch-clamp configuration [21]
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2.3.2 Fluorescence-based Methods
These techniques involve loading fluorescent dyes into the cytosol or cell 
membrane. The flow o f ions between the intracellular and extracellular medium can lead
to a change in the membrane potential or can change the ion concentration in one o f the
mediums. The fluorescent dye loaded in the cell membrane is sensitive to these changes 
and, instead of measuring the ionic current directly, the change in fluorescence signals is 
measured. Optical techniques like total internal reflection fluorescence (TIFR) have been 
used to measure single-channel Ca2+ flux [22],
2.3.3 Flux Assays
This assay involves utilizing radioactive isotopes to trace the cellular influx or 
efflux o f specific ions. The cells that contain the ion-channel of interest are incubated in a 
buffer containing radioactive isotopes for several hours and then washed. The cells are 
then incubated in a solution of agonist; this allows the efflux of the isotope. Finally, the 
radioactive counting o f the cells and supernatant is performed [23].
2.3.4 Binding Assays
Binding assay detects the binding of a compound (ligand) to an ion-channel. This 
assay does not examine how the binding will alter the function of the channel; hence, it is 
not considered a functional assay. A typical binding assay involves using a radioisotope 
to label a known ligand for the ion-channel.
2.4 Patch-clamp Technique
The invention of the patch-clamp technique is accredited to Erwin Neher and Bert 
Sakmann, who in 1976 reported a technique to record single-channel currents from the 
membrane of denervated frog muscle fiber [24]. It was the first device that measured the
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flow o f the current through a single ion-channel. Their technique involved placing a tiny 
glass pipette against a living cell membrane and applying a small amount o f suction to 
form a tight seal between the pipette and cell membrane. This electrical seal had a 
resistance o f order of 50 MQ [25]. Neher and Sakmann soon realized the source o f noise 
in the measured single ion-channel current was due to the leak in the seal between the cell 
membrane and the pipette. In 1981, a group of researchers including Neher and Sakmann 
reported an improved patch-clamp technique. This technique could achieve a “gigaseal”, 
an electrical seal in the order of 109-10n ohms, and thus reduce the noise in the recorded 
channel current by an order of magnitude [26]. Such was the impact of this discovery, 
that in 1991, Erwin Neher and Bert Sakmann were jointly awarded the Nobel Prize in 
Physiology or Medicine for their discoveries concerning the function of single ion- 
channels in the cells. Today, the patch-clamp is the most widely used technique to study 
the electrophysiological properties of biological membranes and widely accepted as a 
gold standard in electrophysiology.
2.4.1 Principle o f Operation
An electrical model for a cell is shown in Figure 2-5. The membrane represents a 
capacitance Cm\ the conductance o f each ion-channel ( g N a ,  g c a ,  g K i ,  g K 2 ,  gi) present in the 
cell is a variable depending on whether the channel is open or closed. The current through 
a single ion-channel can then be represented by a variable conductance in a series with 
the reverse potential o f the channel. The membrane potential E depends on the ion- 
channel currents 7, according to [27]
Eq. 2-1
j
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The current through an individual ion-channel can then be modeled as
l j  =  9j { E  -  E j ) .  Eq. 2-2
Cell interior
INa ICa
gNa gCa
Cm
ENa ECa EK
Extracellular medium
Figure 2-5: Electrical model of a cell. The sodium, calcium and potassium ion-
channels are modeled as a variable conductance depending upon whether 
they are open or closed. The cell membrane is modeled as a capacitor; the 
reverse potential of each channel is modeled as a voltage source.
The patch-clamp technique involves placing a pipette (tip of the pipette is a few 
microns in diameter) with an electrolytic solution against a living cell membrane and 
applying a small amount o f suction. This suction forms a tight electrical gigaseal between 
the cell membrane and the pipette. An Ag/AgCl electrode is then inserted in the pipette 
such that it makes contact with the electrolyte in the pipette and a voltage pulse is 
applied. The ion-channel current now balances the injected current Imj due to the pulse.
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The relationship between the injected current lm} and the ion-channel current is
dE ST
Cm~ d t+ Z u Ij = Iin i' Eq. 2-3
j
If E is constant, the injected current is equal to the ion-channel current, and 
therefore is a direct measure o f the ion-channel current.
2.4.2 Patch-clamp Configurations
Researchers have used different configurations o f the basic patch-clamp technique 
to achieve their goals. The commonly used configurations are: Cell-attached, Inside-out, 
Whole-cell, Outside-out, and Perforated.
2.4.2.1 Cell-attached Configuration
This is the simplest configuration that is achieved as soon as the pipette is placed 
against the cell membrane and a small amount o f suction is applied to form an electrical 
seal between the pipette and the cell membrane. The advantage of this configuration is 
that it can measure the current through a single ion-channel in that patch of the 
membrane. Since the electrical seal resistance is very high, this method requires very 
sensitive and low-noise electronics to record the correct current.
2.4.2.2 Inside-out Configuration
This configuration is achieved with a two-step process. First, an electrical seal 
between the pipette and the cell membrane is achieved by placing the pipette against the 
cell membrane and a small amount of suction is applied (cell-attached configuration).
Step two is to withdraw the pipette quickly so that it tears off the membrane patch. This 
configuration is preferred when the objective is to study the effect o f environmental 
changes on the inside o f the ion channels.
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2.4.2.3 Whole-cell Configuration
This configuration is achieved with a two-step process. First, an electrical seal 
between the pipette and the cell membrane is achieved by placing the pipette against the 
cell membrane and a small amount of suction is applied (cell-attached configuration).
Step two is to apply pulses of suction or voltage to rupture the patch membrane. Unlike 
the inside-out configuration, the cell is still attached to the pipette in the whole-cell 
configuration. As compared to the cell-attached configuration, the larger opening at the 
tip of the pipette is now an advantage since the resistance is lowered and there is better 
electrical access to the inside of the cell. The disadvantage though is that the soluble 
content of the cell will be quickly replaced by the solution in the pipette, and hence, the 
experiment has to be concluded within a shorter time frame.
2.4.2.4 Outside-out Configuration
To achieve the outside-out configuration, first the whole-cell patch is achieved, 
and then the pipette is withdrawn from the cell so that the patch is tom off the cell. The 
patch then reforms itself in the form of a ball at the tip o f the pipette. This configuration 
is useful when the aim is to study the ion-channel function when it is not in the living cell 
environment.
2.4.2.5 Perforated Configuration
The perforated configuration tries to bridge the cell-attached and whole-cell 
configuration. Starting with the cell-attached configuration, special molecules are 
introduced in the pipette that is capable o f perforating the patch membrane. Therefore, 
unlike the whole-cell configuration, the content o f the cell will not be diluted quickly.
The time needed to perforate the patch membrane may vary; hence, this method may not
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be helpful if  the experiment is to be completed in a limited time frame. Another problem 
that could arise is the chance that the process o f patch perforation might cause rupture, 
and this will end up as a whole-cell configuration instead. The different patch-clamp 
configurations are shown in Figure 2-6.
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Figure 2-6: Patch-clamp configurations [28].
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2.5 Planar Patch-clamp
The patch-clamp configurations are widely popular in research labs because they 
provide researchers the flexibility to study various ion-channel functions. However, in its 
simplest form, there are certain aspects of the conventional patch-clamp technique that 
limit the uses of this technology to research work in the laboratory. It takes a highly
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skilled and experienced operator to apply the correct amount o f suction to achieve the 
whole-cell configuration, and to perform simultaneous other activities like replacing the 
solution inside the pipette and recording the current while observing the cell under a 
microscope. The labor involved and the very low throughput make the conventional 
patch-clamp unpopular and unrealistic for wide use in the industry.
There is great interest in developing an automated version o f the patch-clamp that 
can perform recordings o f thousands of cells in parallel and facilitate the screening 
process involved in the drug-discovery cycle. In 2003, a company called Flyion used 
their existing Flip-the-tip technology and launched a fully automated, robot-controlled 
system called Flyscreen 8500 to replace the human operator in the conventional patch- 
clamp technique [29]. However, the technology reported by Flyion still involved using a 
glass pipette and throughput was still less than what the industry demanded.
The idea of having a chip that can hold several thousand micropipettes and allows 
parallel recordings is very intriguing, and since the 1990’s there have been several 
attempts to develop such a chip. Where the conventional techniques exclusively made use 
of a glass pipette, the modem approach makes use o f different materials. In the first 
attempt to fabricate a patch-clamp chip, both optical lithography and low-energy 
electron-beam lithography were used to define patterns on a silicon wafer. We then 
etched these patterns using reactive ion etching and wet etching to achieve orifices that 
were as small as 50 nm in diameter [30]. Even though the processes for fabricating micro 
and nano-structures out o f silicon are well established, silicon does suffer from a few 
problems. A high-density of charge in the silicon can give rise to a parasitic current, 
which is undesirable when dealing with very low ionic currents, and it is also difficult to
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form a gigaseal when using a silicon-based pipette [31]. Glass offers a good alternative to 
silicon, especially when optical methods utilizing fluorescence are used to study ion- 
channel functions. The seal quality is also much better between a glass pipette and a cell 
membrane. The conventional wet etching process on glass yields structures that are not 
perfectly circular and produce poor seal quality. Fertig et al. reported an ion-track etching 
technique that could produce a smooth aperture with a diameter of 1pm or smaller [32], 
[33]. The basic structure o f the planar patch-clamp device is shown in Figure 2-7.
Figure 2-7: Basic structure of a planar patch-clamp device. A) Top view o f the planar 
aperture on a glass chip. B) Cells are suspended and then suction is 
applied. C) A cell forming a seal with the aperture [27], [33].
One of the challenges faced when using conventional or modem day planar patch- 
clamp devices is the ability to reuse the micropipette. Experiments have confirmed that 
once the initial gigaseal between the pipette and the cell membrane is achieved, it is very 
difficult to reproduce another gigaseal for the subsequent capture o f cells. The problem is 
attributed to the debris left over by the initial gigaseal which is very difficult to remove, 
thus hindering the subsequent formation o f another gigaseal [27]. The idea o f a
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disposable pipette is very attractive in scenarios where thousands o f precision recordings 
are needed.
Photolithography has been a dominant technology in fabricating micro patterns 
and structures, but one has little to no control over the chemistry of these structures, 
especially when these patterns and structures are to be fabricated out o f materials made of 
complex functional groups. A lot o f non-lithographic techniques have been used to 
fabricate micro and nano scale structures that can be specifically used in the field of 
chemistry, biochemistry and biology. A technique that involves the use o f a patterned 
elastomer as a mask, stamp, or mold is called Soft Lithography [34]. Soft lithography 
produces a micro or nano scale structure by replica molding, embossing or using self- 
assembly as contact printing. Polydimethysiloxane (PDMS) is a very attractive material 
for soft lithography; it can be easily molded and hence offers great flexibility to make 
complex micro and nano scale patterns. Patch-clamp devices with micrometer scale 
apertures have been fabricated using PDMS [35], [36]. PDMS has also become one of the 
most preferred materials for fabricating microfluidic channels on patch-clamp chips. 
Integrating microfluidic channels on the chip helps facilitate the transport o f cells to the 
pipette site.
2.6 Cell Viability and Cytotoxicity
Cell viability deals with determining whether a cell is living or dead. As 
mentioned in Section 2.2.4, the toxicological property o f the lead compound is important 
for successful drug discovery. The cytotoxicity assays performed during safety screening 
involves exposing a known number of sample cells to the lead compound, and then 
counting the surviving cells. The cell viability and cytotoxicity assays are based on
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various cell functions such as: enzyme activity, cell membrane permeability, cell 
adherence, ATP production, co-enzyme production, and nucleotide uptake activity [37]. 
The commonly used techniques are colorimetric or fluorometric. The colorimetric 
method uses salts that change color depending on a particular cell function. For example, 
the salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) measures 
the activity o f dehydrogenase enzymes. MTT is a pale yellow substrate, but when added 
to living cells, the tetrazolium ring of MTT is cleaved in the mitochondria o f the living 
cells that produce a dark blue formazan. It is then easy to read the living cells with a 
scanning multi well spectrophotometer [38]. The fluorometric method uses dyes and the 
intensity o f these dyes changes according to some particular cell function. For example, 
Calcein-AM can pass through the cell membrane and gets hydrolyzed by the esterase in 
the cell to be converted to calcein, a fluorescence dye. The total esterase activity depends 
on the total number o f viable cells; hence, the fluorescence intensity is directly correlated 
to the number of living cells [39].
CHAPTER 3
PATCH-CLAMP MICROCHIP: DESIGN, MATERIALS, AND 
EQUIPMENT NEEDED FOR FABRICATION
3.1 Patch-clamp Microchip Design
A schematic o f the patch-clamp microchip used for this research is shown in 
Figure 3-1. This microchip comprises of a micropipette, a pipette extension, and a fluidic 
channel. Air bubble (AB) actuators are incorporated to guide the cell to the site of the 
pipette.
Cell sorter
Air bubble  ^
(AB) actuator
Figure 3-1: Schematic o f the patch-clamp device used. The chip has actuators for 
selecting and positioning the cells.
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3.1.1 Input and Output Wells
The cells to be tested are flown into the device via the input well. The input well 
is the interface between the device and the syringe containing the cells to be tested. The 
cells flow through the fluidic channel and the unused cells are collected at the output 
well.
3.1.2 Fluidic Channel Design
The fluidic channel between the input and output wells is designed to carry the 
cells from the input well to the site o f the pipette for recording the currents.
3.1.3 Air-bubble Actuators
The air-bubble actuators allow for selecting the cell and guiding it to the pipette 
site. To achieve cell selection and guidance, the device makes use o f integrated air- 
bubble actuators as shown in Figure 3-2 and Figure 3-3 [40]. These actuators consist of 
chromium micro heaters enclosed inside the actuator well. An external voltage creates 
joule heating in the micro heaters that heats the air inside the chamber to generate the air- 
bubbles. The air bubbles then change the path of the cell and guide it to the pipette site. A 
combination o f actuators is used to achieve cell selection and guidance.
input well 
Ag/AgCI elec trodes?
cell sorting function
output well - 
5 mm
i . ___________ ____________ ___ cell positioning function
Figure 3-2: Close-up view of the cell sorting and positioning actuators [40],
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(b)
Figure 3-3: Cell sorting mechanism. A) The target cell and the target direction is
identified B) Applying a voltage pulse to the actuator on the left, deflects 
the cell into the target direction [40].
3.1.4 Micropipette Design
The micropipette is the most important feature o f the device as the aperture 
defines the quality of the electrical seal. The micropipette orientation and dimension are 
the two most important design elements. The desired length of the micropipette was 15 
pm, but the mask for the micropipette was designed to have a length of 35 pm to 
eliminate alignment issues when the mask for the pattern containing the fluidic channel 
and the micropipette extension are used. Figure 3-4 shows the micropipette’s position 
with respect to the fluidic channel and pipette.
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Figure 3-4: Schematic top-view of the device showing the position of the 
micropipette.
3.1.5 Pipette Extension
The micropipette is connected to a well via a channel as shown in Figure 3-4; this 
combination is called the pipette extension. To form an electrical seal, the well is 
connected to a device that can generate negative pressure. Once the electrical seal is 
achieved, the well holds an Ag/AgCl electrode to record the currents. The typical size of 
the MDA-MB-231cell is between 10 and 20 pm in diameter. Hence, the width and height 
o f the channel has to be greater than the size of the cells. Except for the micropipette 
(height 3 pm), the height of all the other parts is 50 pm. A 3D model o f the device 
showing the close up view of the micropipette is shown in Figure 3-5.
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Fluidic
Channel
Micropipette
Figure 3-5: 3D model o f the device showing the close up view o f the micropipette.
The length, width, and height o f the micropipette are 15 pm, 3 pm, and 3 
pm, respectively. The height of the fluidic channel is 50 pm.
3.2 Materials and Equipment
The materials and equipment needed for this project are divided based on the 
research cycle: fabrication of the patch-clamp microchip, and using the patch-clamp 
microchip to monitor cell viability.
3.2.1 Materials used for Fabricating the Patch-clamp Microchip
The patch-clamp microchip was fabricated using photolithography techniques. 
The following is a list of wafer cleaning chemicals, photoresists, photoresist developer, 
and other chemicals used to fabricate the device.
3.2.1.1 Microscopic Glass Slide
Microscopic glass slides were purchased from Fisher Scientific.
3.2.1.2 Silicon Wafer
The silicon wafers were purchased from Silicon Valley Microelectronics, Inc. 
Some important wafer specifications are: diameter: 100+/-0.5 mm, orientation: <1-0- 
0>+/-l°, type/dopant: N/As, resistivity: 0.002-0.004 ohm-cm, and film: 2000 A +/-5% 
thermal oxide.
3.2.1.3 Ammonium Hydroxide
Ammonium hydroxide, assay 28-30 w/w% was purchased from Fisher Scientific.
3.2.1.4 Hydrogen Peroxide
Hydrogen peroxide, 30% solution, was purchased from EMD Millipore. 
Ammonium hydroxide and hydrogen peroxide were used to clean the organic impurities 
on the silicon wafer.
3.2.1.5 Polvdimethvlsiloxane (PDMS)
PDMS was the material of choice to transfer the device pattern containing pipette, 
actuator wells and the fluidic channel. As discussed in Section 2.5, PDMS is a very 
attractive material to fabricate chips that are disposable and cost effective. Micro and 
nano scale patterns can be easily transferred to PDMS using techniques like replica 
molding, embossing, or by using self-assembly as contact printing. We purchased PDMS 
(Sylgard® 184 Silicon Elastomer Kit) from DOW Coming Corporation.
3.2.1.6 PDMS Curing Agent
PDMS curing agent (Sylgard® 184 Silicon Elastomer Curing Agent) was 
purchased from DOW Coming Corporation.
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3.2.1.7 SU-8 2050
SU-8 2050 is a high contrast, epoxy-based photoresist designed for 
micromachining and other microelectronic applications where a thick, chemically and 
thermally stable image is desired. SU-8 2050 has excellent imaging characteristics and is 
capable of producing very high aspect ratio structures. SU-8 2050 has very high optical 
transmission above 360 nm, which makes it ideally suited for imaging near vertical 
sidewalls in very thick films. SU-8 2050 is best suited for permanent applications where 
it is imaged, cured and left on the device. There are several patterns (pipette, actuator 
wells, input and output wells, and fluidic channel) required on the mold and it is critical 
to appreciate the different dimensions needed for them. Figure 3-5 highlights the height 
variation needed for the pipette and the rest of the pattern. SU-8 (negative photoresist) is 
a common material used to fabricate molds, but in this case, using SU-8 to fabricate the 
pipette mold complicates the process because SU8 has to be coated on the silicon wafer 
with two different thicknesses. To simplify the process, the pipette mold was fabricated 
out of silicon, while the rest of the patterns on the mold were fabricated out of SU-8.
3.2.1.8 SU-8 Developer
The SU-8 developer is used to develop patterns exposed on the SU-8 photoresist.
3.2.1.9 Shipley S1813
Shipley S I813 is a positive photoresist; upon exposure to light, the photoresist 
depolymerizes which makes it easy to selectively dissolve the exposed resist faster with 
the help o f a developer.
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3.2.1.10 LOR 7B
Lift-off resist, LOR 7B, was purchased from MicroChem. LOR 7B, when used in 
conjunction with a photoresist to create a bilayer, can facilitate a high-yield metal lift-off 
process.
3.2.1.11 MF-319
MF-319 was purchased from DOW Chemical. MF-319 is used to develop patterns 
exposed on Shipley 1813 photoresist; it is also capable o f developing LOR 7B.
3.2.1.12 Remover PG
Remover PG was purchased from MicroChem. Remover PG is a solvent stripper 
designed to remove photoresists efficiently and completely. It was also used in the lift-off 
process as a lift-off solvent.
3.2.2 Materials Needed for Monitoring Cell Viability
3.2.2.1 Calee in AM
Calcein is a fluorescent dye and Calcein AM is the acetomethoxy derivate of 
calcein. Calcein AM can be transported into live cells through the cellular membrane, 
which makes it useful for testing the cells’ viability and for short-term labeling of cells.
3.2.2.2 Propidium Iodide
Propidium iodide is a fluorescent molecule, which cannot permeate into living 
cells and is generally used for identifying dead cells in a population.
3.2.2.3 Cell Lines and Culture
Four human breast cancer cell lines have been used for these studies, which 
includes MDA-MB231, MDA- MB231-brain metastatic subline (abbreviated as MB231- 
BR), MB231-BR over-expressing HER2 gene (MB231-BR-HER2), and MB231-BR-
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vector control for the HER2 (MB231 -BR-vector). The cells were transfected to 
overexpress HER2 as described by Palmieri et al. [41]. The MB231-BR, MB231-BR- 
HER2, and MB231- BR-vector cell lines were kindly provided by Dr. Patricia Steeg 
(Women’s Cancers Section, Laboratory o f Molecular Pharmacology, National Cancer 
Institute, National Institutes o f Health, Bethesda, MD). The cells were maintained in 
Dulbecco’s modified Eagle Medium (DMEM, Invitrogen) supplemented with 10% fetal 
bovine serum (FBS, Invitrogen) and 1% penicillin treptomycin solution (Invitrogen).
3.2.3 Equipment Needed for Fabrication
3.2.3.1 Inductively Coupled Plasma Etcher
Inductively coupled plasma etcher (Alcatel 60IE) was used to etch the 
micropipette pattern in the silicon wafer.
3.2.3.2 Oxveen Plasma Etcher
A low powered reactive ion etcher (Technics Micro-RIE, Series 800) was used to 
generate oxygen plasma to bind the PDMS mold on the silicon wafer.
3.2.3.3 Hot Plate
The hot plate was used to dry the wafer after the initial cleaning step. The soft- 
bake required for the photoresist and LOR 7B was also done on the hot plate.
3.2.3.4 Spin Coater
The spin coater, manufactured by Cost Effective Equipment, was used to coat the 
uniform thickness o f the photoresist and LOR 7B on the wafer.
3.2.3.5 UVLight Source andM askAliener
SUSS MicroTec mask aligner was used to align the mask and the wafer; the wafer 
was then exposed to a UV light source.
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3.2.3.6 E-beam Evaporator
The E-beam evaporator from CHA industry was used to deposit chromium (Cr) 
on the micro heaters’ pattern.
3.2.3.7 Optical Microscope
An optical microscope (Olympus Vannox AHMT3) was used during various 
stages o f fabrication to inspect the patterns on the wafer.
3.2.4 Equipment Needed for Monitoring Cell Viability
3.2.4.1 Svrinee Pump
A syringe pump (kd Scientific) was used to pump the cells into the fluidic 
channel.
3.2.4.2 Biopsy Punch
We used 1.5 mm Biopsy punch (Miltex, Inc) to punch holes into the PDMS mold 
at the sites o f input and output wells.
3.2.4.3 Tubes
Tubes were used to connect the syringe pump to the input well to allow the 
transport of cells.
3.2.4.4 Patch-clamp Amplifier
To measure the ion-channel currents, we utilized a patch-clamp amplifier (Dagan 
Corporation, PC-ONE).
3.2.4.5 Disital Oscilloscope
We record the ion-channel currents using a digital oscilloscope (Tektronix TDS 
1012B).
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3.2.4.6 Fluorescence Microscope
A fluorescence microscope (Olympus 1X51) was used to capture the fluorescent 
signals from the Calcein AM and Propidium Iodide.
CHAPTER 4
PATCH-CLAMP MICROCHIP: FABRICATION
The entire microchip fabrication can be divided in four major steps: 1) Fabricating 
the mold on a silicon wafer; the mold contains the patterns for the pipette, actuator wells, 
input and output wells, and the fluidic channel 2) Transferring the patterns on the mold to 
PDMS 3) Fabricating air-bubble actuators on a glass substrate 4) Binding the PDMS 
replica with the air-bubble actuators on the glass substrate.
4.1 Mold Fabrication
The mold contains the patterns for the pipette, actuator wells, input and output 
wells, and the fluidic channel.
4.1.1 Pipette Mold
As mentioned earlier, the pipette is the most critical part of the device due to the 
specific dimensions needed. The traditional top-down approach was used to fabricate the 
pipette out o f silicon. First, the p-type silicon wafer (<100>) was cleaned using 1:1:5 
solutions of the ammonium hydroxide, hydrogen peroxide and deionized water at 80° C 
for 15 minutes. The wafer was then dried on a hot plate at 100°C for 10 minutes. A one 
micron thick layer o f Shipley 1813 photo resist was uniformly coated on the wafer using 
a spin coater (Brewer Science, Model 100). The wafer was then baked on a hot plate at 
100° C for 90 s and cooled at room temperature for five minutes. The pipette mask was
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mounted on a SUSS MicroTec mask aligner, and the wafer was loaded in the machine 
and exposed. The data sheet for photo resist 1813 specifies the exposure time and the 
energy required for a good transfer o f pattern. In most cases, the exposure time and 
energy required varies according to the life of the light source. For this machine, the 
exposure time between 6-10 s and a power o f 1000 watts has always proved sufficient to 
successfully transfer the pattern onto the wafer. The exposed wafer was developed in 
MF319 for around 90 s, rinsed with DI water, and baked on a hot plate at 100° C for 60 s. 
To etch the pattern, the wafer was loaded in an inductively coupled plasma etcher 
(Alcatel 601E). The deep reactive ion etching (DRIE) process was used; each cycle is 
composed of the etching step followed by the passivation step. First, the silicon was 
etched by flowing SF6 gas at a rate o f 100 seem (standard cubic centimeter per minute) 
for 4 s and then C4F8 was flown at a rate of 70 seem for 6 s to protect the sidewalls. The 
RF power was maintained at 800 W and the plate voltage was maintained at 35 V for the 
etching step. It took around 15 cycles to etch 3 pm of silicon pipette pattern. After the 
etching process, the photoresist on the wafer was cleaned with acetone followed by an 
IPA and DI water rinse. The final pipette dimensions are: 35 pm, 3 pm, and 3 pm for 
length, width, and height, respectively. Figure 4-1 shows the pattern generated in the 
plane containing the cross-section of the pipette extension (input well and the channel 
connecting the pipette), and the fluidic channel.
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Spin coat the positive 
photo resist
Expose the wafer to 
Micro-pipette mask
Develop the exposed 
wafer
Perform Deep 
Reactive Ion Etching
Final structure:
Micro-pipette die
Figure 4-1: Process flow for fabricating the pipette mold on the silicon wafer.
4.1.2 Mold for Actuator Wells. Input and Output Wells, and Fluidic Channel 
A standard clean was performed on the silicon wafer with the pipette mold to 
remove organic waste deposited during the etching step. The required thickness for this 
mold is 50 pm as discussed in Section 3.1. The data sheet for SU-8 2050 specifies the 
resist to be spun at 3000 rpm to achieve 50 pm thickness [42]. The deposition was 
followed by a soft bake at 95° C for 6 minutes and then the wafer was cooled at room 
temperature for 10 minutes to remove any unwanted wrinkles. The wafer was then 
aligned with the mask mounted on the mask aligner and exposed to a light source of 350- 
400 nm and energy of 150-215 mJ/cm2. A post exposure bake at 95° C for six minutes 
was performed before immersing the wafer in the SU-8 developer for 5-7 minutes to
Silicon
Wafer
S1813
□Micro-pipettemask
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develop the patterns on the wafer. Finally, the wafer was rinsed with IPA and DI water 
and dried with nitrogen. The process flow shown in Figure 4-2 shows the patterns 
generated in the plane containing the cross-section of the pipette extension (input well 
and the channel connecting the pipette), and the fluidic channel. It is now easy to 
appreciate why the length of the pipette in the pipette mask is 35 pm and not 15 pm, 
which is what is desired. For a pipette length of 15-pm, any alignment error due to the 
machine or the operator can create a scenario where the pipette is either not connected to 
the pipette extension or the fluidic channel. The longer length of the pipette ensures there 
is no break along the path containing the pipette extension, pipette and the fluidic 
channel. A 3D model o f the SU-8 mold is shown in Figure 4-3.
Spin coat negative photo 
resist
Expose the wafer to the 
fluidic mask Silicon wafer
Develop the exposed 
wafer SU-8 2050
Fluidic maskPerform hard bake
Final structure: 
SU-8 die
Figure 4-2: Process flow showing the pattern generated in the plane containing the 
cross-section of the pipette extension and the fluidic channel.
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Input well
Micropipette Output well
Figure 4-3: 3D model o f the SU-8 mold. The mold for input and output well, fluidic 
channel, air-bubble actuators, and Ag/AgCl electrode is made out o f SU- 
8 (red color). The mold for the micropipette is made out o f silicon (blue 
color)
4.2 PDMS Replica
The curing agent was added to the PDMS base 1:10 ratio and stirred well, which 
caused air, visible as air bubbles, to be trapped in the mixture. The mixture was then 
placed in a degassing chamber and the pressure was gradually reduced to less than 200 
Torr for 30 minutes. This mixture was then poured over the mold and baked in a 
conventional oven for three hours at 70° C. After removing the mold from the oven, the 
PDMS was carefully peeled off the mold and the replica was obtained.
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4.3 Air-Bubble Actuators
The glass slide was first cleaned in a solution containing 1:1:5 o f ammonium 
hydroxide, hydrogen peroxide and DI water, respectively, at 80° C for 15 minutes. A 700 
nm thick layer o f LOR 7B was deposited on the glass slide by spinning the slide in the 
coater at 3000 rpm for 45 s. The glass slide was soft baked on the hot plate at 180° C for 
three minutes and subsequently cooled at room temperature for five minutes. The soft 
bake temperature and time are critical as they have a direct effect on the undercut rate 
[43].
Next, a one-micron thick layer of S1813 resist was deposited on the glass slide 
using a spin-coater spinning at 3000 rpm for 50 s. The glass slide was then soft baked on 
a hot plate at 100° C for 90 s followed by cooling it at room temperature for five minutes. 
The micro heater pattern was then transferred on the glass slide using the mask aligner 
and immersed in MF319 solution for 60 s to develop the pattern. Following a DI water 
rinse, the undercut pattern was investigated under the microscope continuously. A good 
undercut ensures easy lift off; if  the undercut was not prominent, the slide was immersed 
back into the developer solution and reinvestigated for the undercut.
After achieving a good undercut, a 200 nm thick layer o f chrome was evaporated 
on the slide. The slide was then immersed in a bath of Remover PG solution maintained 
at 60° C for three hours. After three hours, if the resist stack was not lifted off completely, 
the Remover PG bath was changed and the slide was re-immersed for additional time 
until the entire resist stack was completely removed. Finally, the glass slide was cleaned 
with IPA and DI water. The complete fabrication process for the air-bubble actuator is 
shown in Figure 4-4.
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Spin coat LOR and positive 
photo resist
Expose the wafer to the 
m icro-heater m ask
Develop the exposed wafer
Evaporate Chromium (Cr)
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the LOR and photo resist □
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Slide
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(Cr)
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Mask
Final structure:
M icro-heaters on g lass slide
Figure 4-4: Process flow for fabricating the air-bubble actuators.
4.4 Binding PDMS Replica with the Air-Bubble Actuators
To bond the PDMS replica with the glass slide, the PDMS replica was treated 
with oxygen plasma (35 seem, 60 W, 10 s) and aligned on the glass slide containing the 
micro-heaters.
CHAPTERS
PATCH-CLAMP MICROCHIP: EXPERIMENTAL SETUP AND 
PROTOCOL
5.1 Experimental Setup
The objective o f the experiment is to establish that the fabricated planar patch- 
clamp microchip is a capable alternative to measure cell viability. The experiments are 
set up in a manner such that both fluorescence imaging and ion-channel currents can be 
recorded simultaneously. The fluorescence images are recorded with an Olympus 
inverted fluorescent microscope (Olympus, Inc.), while the ion-channel current is 
recorded by a combination of a patch-clamp amplifier (Dagan Corporation, PC-ONE) and 
a digital oscilloscope (Tektronix TDS 1012B). It is very important to note this in order to 
minimize or even eliminate the EM interference. Ideally, patch-clamp recordings are 
performed in a Faraday cage to minimize or even eliminate the electromagnetic (EM) 
interference. Proper electrical shielding and grounding practice is observed to reduce or 
eliminate the noise. The cells are pumped into the input well of the device using a syringe 
pump. The microchip with assembled Ag/AgCl electrodes and tube connections is shown 
in Figure 5-1.
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Figure 5-1: Fabricated microchip with assembled Ag/AgCl electrodes and tube 
connection at input well for cell flow.
5.2 Experiment Protocol
The cells were stored in the DMEM buffer; hence, it was important to record the 
resistance o f the device with only the buffer flowing through it. The first step of the 
experiment was to measure the open pipette resistance. To measure this resistance, the 
DMEM buffer without the cells was flown in the device and then 20 mV, 40 Hz square 
wave pulse was applied, and the recorded ion-channel current was used to calculate the 
seal resistance. Next, the DMEM buffer containing cells was pumped into the input well 
of the device using the syringe pump. The flow of the cells was observed under the 
microscope and the cell sorting and positioning mechanism was used to guide the cell to 
the site of the pipette. Negative pressure was then applied to form the electrical seal 
between the cell and the pipette. Following the cell capture, a 20 mV, 40 Hz square wave 
pulse was applied to the Ag/AgCl electrode. The ion-channel current and the 
fluorescence image of the captured cell were recorded simultaneously.
CHAPTER 6
PATCH-CLAMP MICROCHIP: RESULTS AND DISCUSSION
6.1 Ion-channel Current and Seal Resistance of Cell
An optical image of a captured cell by the micropipette is shown in Figure 6-1. To 
record the ion-channel current, a square-wave voltage pulse of 20 mV, 40 Hz is applied. 
The recorded ion-channel current through the device over a period o f time is shown in 
Figure 6-2. As expected, under the open pipette condition, the current through the device 
is higher, and the calculated seal resistance is ~ 4 MO. Once the cell is captured, the seal 
between the cell membrane and the pipette offers a high-resistance. The current through 
the device is now a combination of the ion-channel current and the leakage current 
through the seal, with the ion-channel current being the dominant source. The curve T = 0 
minute corresponds to the first ion-channel current recorded after the cell is captured. At 
this instance the cell has the highest viability, and hence, the lowest ion-channel current 
of -280 pA and largest seal resistance o f -22.0 MO. As mentioned in Section 2.6, the cell 
membrane permeability is an indicator o f cell viability. Even though the buffer surrounds 
the cell, over a period of time, the cell will lose its viability and, as the cell starts to die, 
the ion-channel current increases. The recording at T = 30 minutes shows that the ion- 
channel current has increased and the corresponding seal resistance has decreased from
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22.0 MQ to 6.5 MD. Eventually after 2 hours the cell is dead and the current is back to 
the level o f open pipette and seal resistance is ~ 4 MQ.
Figure 6-1: Close up view of captured cell [12].
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Figure 6-2: Current through the device over the test period. The current is in response 
to a 20 mV, 40 Hz square wave pulse [12].
6.2 Fluorescence Images of Cell
As mentioned earlier, the ion-channel currents and the fluorescence images o f the 
cell were simultaneously recorded. Figure 6-3 shows the representative fluorescence 
images o f the captured cell. As expected, immediately after its capture, the living cell has
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brighter green fluorescence due to the fact that calcein AM can permeate into living cells 
through the cellular membrane. Propidium iodide (PI), however, cannot permeate into 
living cells and hence the cell image shows a dimmer red fluorescence. After 120 minutes 
the cell loses its viability, which reverses the intensity o f the fluorescence. PI now 
permeates into the dead cell and therefore the cell image shows brighter red fluorescence, 
while the green fluorescence, due to Calcein AM, grows significantly dimmer.
Figure 6-3: Fluorescence images of the cell, the green fluorescence is due to Calcein 
AM and red fluorescence is due to PI [12].
6.3 Comparing the Seal Resistance and Fluorescence Intensity
To validate the viability o f this platform, the seal resistance of the device was 
compared with the recorded PI fluorescence images of the cell. In Figure 6-4, the blue
t O minu tet 0 minu te
^L ive  to dead cell
t~ 1 20 m in u te s  ^ B t - 1  20 minute?,
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curve represents the variation in seal resistance of the device over a period o f time while 
the red curve represents the variation in PI fluorescence intensity. At T = 0, the cell is 
alive and the recorded seal resistance is ~ 22 M£i, while the recorded intensity o f the PI 
fluorescence is low. At T = 120 minutes, the cell is dead and the recorded seal resistance 
has decreased to ~ 4 MQ, while the recorded intensity o f PI fluorescence has increased 
significantly.
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Figure 6-4: Representative measured seal resistance of the captured cell and 
corresponding PI fluorescence intensity. Inset at T = 0 is the PI 
fluorescence image of the live cell (immediately after capture) and inset at 
T = 120 minutes is the PI fluorescence image of the dead cell [12].
In order to obtain systematic experimental results, about 12 cells from each cell 
line (cell line 1 MB231; cell line 2 MB231-BR-vector; cell line 3 MB231-BR-HER 2; 
cell line 4 MB231-BR) were tested. It took about two to four hours to complete the 
experiments for each cell. Representative experimental results for five cells from each
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cell line are plotted in Figure 6-5. The recorded ion-current values show a consistent 
decrease in the seal resistance as the cell loses its viability, until finally the seal resistance 
reaches the value of open pipette. Based on these results, it is very clear that the change 
in seal resistance correlates very well with the health (alive or dead) of the cell.
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Figure 6-5: Summary of seal resistance change for four cell lines, a change in the seal 
resistance shows similar trend, a) cell line 1 MB231; b) cell line 2 MB231- 
BR-vector; c) cell line 3 MB231-BR-HER 2; d) cell line 4 MB231-BR [12].
6.4 Summary
In this chapter we discussed the performance of the patch-clamp microchip. The 
ion-channel currents for 12 cells from each cell line (cell line 1 MB231; cell line 2 
MB231-BR-vector; cell line 3 MB231-BR-HER 2; cell line 4 MB231-BR) were recorded 
over a period of time and simultaneously fluorescence images o f the cell were also 
recorded. The validity o f the patch-clamp microchip as a viable technical platform for 
real-time monitoring of cell viability was established after comparing the change in seal 
resistance and the change in intensity o f fluorescence images.
CHAPTER 7
PATCH-CLAMP MICROCHIP: CONCLUSIONS AND FUTURE 
WORK
7.1 Conclusions
Systematic measurements o f the cell’s electrical properties (e.g., ion channel 
current and seal resistance) were performed using PC microchips. All o f the experimental 
results indicate that PC microchips provide a viable technical platform for monitoring cell 
viability in real time. This was confirmed by simultaneously carrying out the experiments 
using the conventional technology i.e. monitoring the changes o f the fluorescence images 
o f cells. Therefore, given its simplicity o f direct electrical measurement o f cells without 
fluorescence labeling, the technical platform based on PC microchips may pave a way for 
high efficiency drug effect analysis on cancer cells given their direct electrical 
measurements on cells and the fluorescence dye labeling o f the cells can be completely 
avoided.
7.2 Future Work
This technique can quantify the ion current and seal resistance o f single cells, 
thereby providing the quantified information for specific types o f cells, which would 
greatly benefit ion-channel based drug discovery [44], [45].
45
46
Future work will focus on the real-time monitoring o f controlled drug effects on 
cells using this platform. This will be achieved by integrating a controlled drug release 
microfluidic platform with PC microchips.
CHAPTER 8
FET BASED BIOSENSOR: INTRODUCTION
Proteins, including enzymes, antibodies and some hormones, are common targets 
in clinical diagnosis. The ability of an antibody to identify and form complexes with 
corresponding antigen is highly specific and forms the basis of immunoassay techniques. 
ELISA is the most commonly used conventional enzyme immunoassay technique but has 
several limitations. To begin with, these techniques require a laboratory setup with a 
highly qualified technician who can execute the complex multistage process while 
analyzing the results. The analysis can take several hours, making it unsuitable for 
applications where quick determination o f analyte is required. Smart biochips made of 
novel materials and structures are now capable of performing some of the basic in vitro 
diagnostic tests involved in immunoassays. The discovery o f novel materials like carbon 
nanotube (CNT) has opened up new opportunities to engineer biosensors made from 
individual CNT that are ideally capable of detecting biomolecules on a molecular level.
Since every atom in a CNT is a surface atom, they form an ideal class of ID 
nanostructures that could exhibit ideal sensitivity at a single molecular level [46]. The 
transfer o f charge from one electrode to another is a very important aspect in any 
electrochemical reaction, and it has been shown that CNTs promote electron-transfer 
reactions of proteins [47]. Most o f the modem biosensors have exploited the
47
48
semiconducting nature of CNT to design a label-free field-effect transistor (FET) based 
immunosensor (biosensor that exclusively monitors the antibody-antigen interaction). 
Even though biosensors made out of a single CNT are ideally capable o f detecting a 
single molecule, the biggest hurdle in using CNT for biosensors is the process involved in 
assembling this nanostructure into the sensor. For sensors based on ID structure like 
CNT, there are huge variations in the device’s characteristics. Due to these variations, it 
is very important to calibrate each sensor before use. It is a major challenge to develop a 
reusable CNT based sensor that can be calibrated easily before deployment in a real-life 
scenario.
To avoid the fabrication complexity involved with a single CNT immunosensor, 
we have developed an FET based biosensor, in which the channel is fabricated out of 
carbon nanotubes thin film (CNTF). The CNTF channel between the source and drain 
electrodes was assembled using electrostatic layer-by-layer assembly (LBL). To 
investigate the potential o f the device as an immunosensor, we used the bio-affinity 
interaction between Protein A and rabbit IgG to model the antibody-antigen interaction.
8.1 Key Accomplishments of the Project
The key accomplishments of the project include the fabrication of the FET device 
using LBL assembly and the verification o f the behavior o f the device as a p-type 
transistor. To study the antibody-antigen interaction, the bio-affinity interaction between 
Protein A and rabbit IgG was used as a model and initial results suggest that the device 
can detect IgG concentrations as low as 1 pg/mL.
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8.2 Outline of FET Based Biosensor Project
In CHAPTER 9 we begin with a discussion on conventional techniques used in 
immunoassays, their disadvantages, and make a case for the use o f biosensors. The 
various types of biosensors and the impacts o f nanotechnology on these sensors are 
discussed. A detailed study of carbon nanotube and its application as an electrochemical 
sensor is presented, along with a brief discussion on protein immobilization and its 
significance. Next, a discussion on the challenges involved in fabricating a sensor made 
out of single CNT and a case for carbon nanotubes thin film (CNTF) is made. Finally, the 
fabrication techniques, with a focus on layer-by-layer self-assembly and electrical 
properties of CNTF, are discussed.
In CHAPTER 10 the design aspects of the device are presented, as well as a 
mention of the various materials and equipment required to fabricate the biosensor.
A detailed fabrication process for each component o f the biosensor is discussed in 
CHAPTER 11.
CHAPTER 12 begins with an introduction to the experimental setup and the 
protocol used, continues with a discussion on the behavior of the device as a transistor, 
and ends with a discussion on the performance of the device as a biosensor to detect the 
bio-affinity interaction between Protein A and rabbit IgG.
In CHAPTER 13 we summarize the FET based biosensor project and discuss its 
future direction.
CHAPTER 9
FET BASED BIOSENSOR: RESEARCH BACKGROUND
The immune system in our body protects us from microorganisms and other 
chemical agents. This system is made up of special cells, proteins, tissues and organs and 
is continuously monitoring the body for the presence of pathogens (foreign substance like 
bacteria, virus, or other microorganisms). More specifically, the immune system looks for 
the presence o f an antigen; which is a molecule (mostly protein) attached to a pathogen. 
The presence of an antigen triggers the immune system to produce a specialized protein 
called an antibody that locks onto the specific antigen and eventually destroys the 
pathogen. The world we live in today is a complex place, where we consume more 
processed foods, commonly travel across continents, produce industrial waste that 
contaminates water sources, and face the possibility of biological and/or chemical 
warfare. Advancement in science and diagnosis o f diseases over the last century has 
improved human health significantly, but there are a growing number o f factors, 
including food and water, that could have an adverse effect on our health or could prove 
to be fatal. It is a never-ending quest to develop technologies that can detect biological 
and chemical pathogens, contaminants or other agents that can cause the spread o f a 
disease and infection. The field of pathogen detection is expansive, and as shown in
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Figure 9-1, research areas like water and environmental control, food industry and 
clinical diagnosis account for more than two-thirds of all the research in this field [48].
Areas of interest for pathogen detection
Defense
Other Areas
Water 
&
Environment
Food Industry
Clinical
Figure 9-1: Areas of interest for pathogen detection [48].
9.1 Diagnostic Targets
In conventional diagnosis, the sample taken from the patient travels to a 
laboratory where a skilled technician runs various diagnostics tests to confirm whether 
the patient tests positive or negative for a particular disease. Any clinical diagnostic test 
is designed to detect a specific analytical ‘target’ in the patient’s sample. The target list 
includes proteins, nucleic acids, metabolites, drugs, dissolved ions, human cells, and 
microbes. The sample can be a patient’s blood, saliva, urine, or other bodily fluids or 
semi-fluids. When it comes to detecting pathogens, there are two popular diagnostic 
targets: nucleic acids and proteins.
52
9.1.1 Nucleic Acids
The diagnosis based on nucleic acids is often referred to as “molecular 
diagnostics”. There are two approaches to molecular diagnosis to measure the DNA or 
various types o f RNA to assay particular genomic or genetic details o f a patient, or to 
assay the nucleic acid sequence unique to the invading pathogens. The assay is based on 
the isolation, amplification, and quantification o f the target nucleic acid sequence. 
Techniques like Polymerase Chain Reaction (PCR) are very common in molecular 
diagnostics. Kary B. Mullis developed the PCR technique in 1983 and in 1994 he and 
Micheal Smith were awarded the Nobel Prize in chemistry for their work. These 
techniques are highly selective and sensitive, but they are also more expensive, 
cumbersome and time consuming than other assay techniques [49].
9.1.2 Proteins
Proteins, including enzymes, antibodies and some hormones, are common targets 
in clinical diagnosis. The ability o f an antibody to identify and form complexes with the 
corresponding antigen is highly specific and forms the basis o f immunoassay techniques. 
This extremely specific affinity of antigen-antibody lends immunoassays with a very high 
level o f sensitivity. There are multiple ways to detect this specific antibody-antigen 
(immunoagents) interaction (immunointeraction), and the most common approach 
involves immobilizing one of the immunoagents on a substrate and then exposing the 
immobilized immunoagent with its corresponding immunoagent solution. The exposure 
leads to interaction and eventual formation of an antibody-antigen complex on the 
substrate. The detection process quantifies the complex formed on the substrate. To
53
simplify the quantification process, one o f the immunoagents is attached with commonly 
used labels like radioactive markers, enzymes or fluorescent dyes.
The use of radioactive markers dates back to 1960 when Solomon Berson and 
Rosalyn Yalow successfully measured endogenous plasma insulin using radioisotope 
[50]. Even though the radioimmunoassay (RIA) technique was hugely popular, and 
earned Yalow the Nobel Prize in physiology and medicine in 1977, this technique 
required special facilities and there was great concern regarding the safety o f laboratory 
personnel when handling radioactive waste. Alternatives were explored, and in the early 
1970s, the idea o f using enzymes was put forth at ERIAC (European Radiolmmuno Assay 
Club). Peter Perlmann and Eva Engvall conceptualized and later developed the enzyme- 
linked immunosorbent assay (ELISA) technique, publishing their first paper in 1971 that 
demonstrated the quantitative measurement o f IgG in rabbit serum with alkali 
phosphatase [51]. Today, ELISA is the most commonly used enzyme immunoassay 
technique with different schemes. The direct ELISA technique is the simplest of 
schemes, whereas the ‘sandwich’ method and competitive binding method are the most 
widely used.
These conventional techniques however have several limitations. To begin, they 
require a laboratory setup with a highly qualified technician who can execute the 
complex multistage process and analyze the results. The analysis can take several hours, 
making it unsuitable for applications where quick determination of analyte is required. 
Finally, equipment miniaturizing and measurement automation is difficult or impossible.
Progress in nanotechnology has made it possible to miniaturize many of the tools 
used in conventional immunoassay tools. There is immense interest and progress in
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point-of-care diagnosis (POC). POC diagnostic tools employ in vitro diagnostic tests, 
which are tests that do not require any sample pre-preparation, a well-equipped 
laboratory setup or a skilled technician. At the heart o f any POC system is a biosensor. 
The term ‘biosensor’ or ‘immunosensor’ is used for alternative immunoassay systems 
that overcome the limitations of conventional immunoassay techniques. These 
alternative systems are still based on the same basic principles of antigen-antibody 
interaction used in conventional assays, but as they are automated, they are more 
efficient, sensitive, and also faster than their conventional counterparts and have the 
ability to acquire data directly [52]. The biggest advantage o f POC diagnosis is the short 
amount o f time required to get an “answer”, as the result is available in seconds 
compared to hours [53],
9.2 Biosensors
Leland Clark was a pioneer in the development o f the heart-lung machine. Clark 
was an experienced physiologist who, during a surgery, could correctly adjust the oxygen 
levels by visually judging the redness o f the blood. In his attempt to automate the process 
o f oxygenating blood circulation, he developed the oxygen sensor, or more commonly 
known as the Clark electrode. Later, while he was trying to calibrate the electrode 
(deoxygenating it) by adding small amounts of enzyme glucose oxidase, he realized he 
could use his device as a glucose sensor. In doing so, Clark had built the first ever 
biosensor. In 1992, at the World Congress on Biosensors in Geneva, Switzerland, he was 
honored with a special recognition of “Father o f Biosensors” [54].
Lazcka et al. have managed to quote a source that defines a biosensor [48]. 
According to their source, “Biosensors are analytical devices incorporating a biological
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material (e.g., tissue, microorganisms, organelles, cell receptors, enzymes, antibodies, 
nucleic acids, natural products, etc.), a biologically derived material (e.g., recombinant 
antibodies, engineered proteins, aptamers, etc.) or biomimic (e.g., synthetic catalysts, 
combinatorial ligands and imprinted polymers) intimately associated with or integrated 
within a physicochemical transducer or transducing microsystem, which may be optical, 
electrochemical, thermometric, piezoelectric, magnetic or micromechanical.'” The basic 
block diagram of a biosensor is shown in Figure 9-2. In general, a biosensor is composed 
o f two parts: a) a sensor system that allows interaction between biological elements, and 
b) a transducer that generates a signal employing principles of biological molecular 
recognition.. Most of the biosensors use three main biological elements for recognition, 
namely enzymes, antibodies and nucleic acids.
SAMPLE
I biologically
SENSOR
TRANSDUCER
sensitive
coating
OUTPUT
Figure 9-2: Basic block diagram of a biosensor [55].
Based on the transducing mechanism, biosensors can be classified as optical 
biosensors, gravimetric biosensors and electrochemical biosensors.
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9.2.1 Optical Biosensors
The good selectivity and sensitivity o f optical biosensors make them the most 
popular types o f biosensors. While fluorescence detection is the most commonly used 
technique in optical biosensors, there are increasing numbers of optical biosensors based 
on other smart techniques such as surface plasmon resonance (SPR), and photonic crystal 
nanostructures.
Fluorescence detection has been used in conventional techniques like ELISA and 
PCR in which immunoagents are conjugated with fluorescent compounds. In fluorescent 
compounds, a valence electron can absorb light from an external excitation source and 
make a transition to an excited singlet state. When this electron returns to its ground state, 
it emits a photon (light) with lower energy (longer wavelength). There are many types of 
fluorescent markers, but the most commonly used is fluorescein isothiocyanate (FITC) 
and quantum dots that are increasing in popularity due to the fact that they produce 
stronger fluorescent signals and increased sensitivity. A technique based on the transfer 
of energy from donor fluorophore to an acceptor fluorophore, also called fluorescence 
resonance energy transfer (FRET), has been used to detect listeria and salmonella 
contamination in food [56]. Quantum dots are now being used in FRET since they make 
excellent donors [57].
When light (photon) is incident upon a solid or liquid, the electrons at the surface 
are set into oscillations, and Surface Plasmon occurs when the frequency o f electron 
oscillation is equal to the frequency o f incident photon. Under specific conditions, the 
incident photon couples with the surface plasmon to generate electromagnetic waves 
called Surface Plasmon Polaritons (SPP). The boundary of a metal-dielectric interface
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can guide these electromagnetic waves over a very short distance (< 100-200 nm) before 
they lose their energy due to absorption in the metal or radiation into free space. These 
SPP are very sensitive to changes in thickness or refractive index along the path they 
travel near the boundary o f the metal-dielectric interface. An SPR based biosensor 
measures this change in refractive index due to the adsorption of antigen-antibody [58].
It was Lord Rayleigh who first studied the propagation o f electromagnetic waves 
in periodic media. In early 1887, he studied crystal structures that could prohibit light 
propagation through their planes. In 1987, researcher Eli Yablonovitch published a paper 
on his attempts to achieve threshold-less LASER by increasing reflective feedback levels 
into the light-emitting medium [59], In the same year, researcher Sanjeev John published 
a paper where he was trying to localize light by using a periodically varying refractive 
index [60]. Later, they both realized that they were investigating the same type of 
structure, and Eli Yablonovitch coined the term Photonic Crystals. According to Eli 
Yablonovitch, to be called a photonic crystal, the crystal must satisfy two important 
criteria: the structure has to have 2D or 3D periodic structure and the photonic band 
structures should have a high index o f  contrast (> 2) [61]. Photons behave similarly to 
electrons in photonic crystals due to the presence o f photonic band gap (PBG). Photonic 
crystals can block a range of photons; photonic band gap is the range of photon energy or 
frequency that cannot propagate through the photonic crystal. The fabrication of photonic 
crystals is complicated, but simpler techniques like using nano porous hydrogel to 
fabricate photonic crystal have been used to detect immunoglobulin G (IgG) antibody 
[62].
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9.2.2 Gravimetric Biosensors
Gravimetric biosensors detect the change in mass following the antigen-antibody 
complex formation, and the most common approach to detect the change in mass is to use 
piezoelectric detectors. For a piezoelectric material, the resonance frequency changes 
when mass is added to the material. The relationship between resonance frequency 
change and the mass is given by Sauerbrey equation:
- 2 . 3  x  1 0 6Fo2Ara 1
AF = -----------   5------ . Eq. 9-1
Where AF is the change in resonant frequency in Hertz, F0 is the resonant 
frequency of the crystal in MHz, Am is the mass deposited in grams and A is the area over 
which the mass is deposited [63].
These types o f biosensors have been used to detect bacteria using probes modified 
with immobilized antibodies [64], [65]. The resonant frequency of the probe is then 
measured using a quartz crystal microbalance (QCM).
9.2.3 Electrochemical Biosensors
As mentioned earlier, optical biosensors are the most commonly used biosensors 
due to the fact that they have good sensitivity and selectivity; even conventional 
techniques like ELISA are based on optical detection and still remain very popular. 
Optical biosensors do suffer from several drawbacks, however, including bulky 
monochromators, light sources and detectors. The most important limiting factors are the 
minimum sample volume and the path length requirements that are set by the Lambert- 
Beer law to achieve certain performances [66],
Electrochemical biosensors come across as the most promising alternatives to 
these optical biosensors and are more common in monitoring and the diagnostic test in
59
clinical analysis. Advancements in micro and nano scale fabrication make it possible to 
miniaturize the electronics involved in electrochemical biosensors, leading to lower-cost, 
better multiplexing, and to the possibility of high-throughput analysis while using very 
small volumes o f samples. The biggest advantage that electrochemical sensors have over 
optical counterparts is the fact that the volume o f the sample does not affect the 
sensitivity of the electrochemical sensors.
Any electrochemical biosensor is designed to detect the changes in electron 
(charge) transfer (either voltage or current changes) when immunoagents interact. 
Depending on the parameter detected, these sensors are classified as: amperometric 
(current), potentiometric (constant voltage), or impedimetric (alternating 
voltage/impedance).
9.2.3.1 Amperometric Electrochemical Biosensors
Detecting the current is the most commonly used technique in electrochemical 
sensors. The sensors are biased such that the immunointeraction produces a current 
directly or indirectly, and usually the linear relationship between the current and the 
analyte concentration is known. Based on the known linear relationship, the 
concentration can be directly evaluated from the measured current. There are certain 
situations where the immunointeraction will not produce any charge transfer. In such 
cases, redox mediators are introduced that are able to reversibly exchange charge 
between the sensor and immunoagents [67], [68].
9.2.3.2 Potentiometric Electrochemical Biosensors
These sensors monitor the change in potential at the working electrode with 
respect to a reference electrode. The field-effect is the dominant technique used in these
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sensors. Traditionally, an ion-sensitive field effect transistor (ISFET) involved using a 
reference electrode to detect biological elements, but there is a very useful variation of 
ISFET utilizing the semiconductor field-effect for detection [69]. The application o f these 
types o f electrochemical biosensors was not very common in the past and there are 
certain problems associated with these devices that limit the growth. The biggest 
challenges involved in using these sensors are a) fabrication and packaging, b) poor 
reproducibility, c) poor detection limits, and d) poor device stability.
9.2.3.3 Impedimetric Electrochemical Biosensors
Impedimetric technique is more commonly known as electrochemical impedance 
spectroscopy (EIS). The commonly used structure makes use of interdigitated electrode 
array structure as shown in Figure 9-3. The detection technique involves applying a small 
voltage across two electrodes and sweeping the frequency while simultaneously 
recording the impedance (conductance). Since the impedance is a complex function of 
frequency, it is easier to detect any change in dielectric constant due to the formation of 
complexes after the immunointeraction. The main advantage o f these sensors is they do 
not need any kind o f labels as compared to other electrochemical sensors that need labels. 
The label free approach makes these sensors suitable for rapid detection of foodbome 
pathogenic bacteria [70], [71]. However, the detection limits for these sensors are poor 
when compared to other traditional techniques [48].
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Figure 9-3: An interdigitated electrode (IDE) array.
9.3 Nanotechnology and Biosensors
Nanotechnology is a multidisciplinary field that involves studying, creating and 
manipulating materials to develop devices and systems. Typically, at least one dimension 
of the nanomaterial and nanostructure is in the range of 1-100 nm. These novel 
nanomaterials and nanostructures display unique physical and chemical properties due to 
quantum size effect, surface effect, and quantum-tunnel effect. Fundamental concepts in 
condensed matter physics drive the developments in artificial inorganic nanostructures. It 
was Leo Esaki who first introduced the concept of ‘artificial solid’ when he developed 
novel semiconductor quantum devices, in which the tunneling of electrons could be 
systematically controlled [72]. In 1973, Esaki was awarded the Nobel Prize in Physics. 
The quantum mechanical scattering of the valence electrons by the atoms is responsible 
for the electronic and optical properties o f a semiconductor. In the first artificial solids, 
the semiconductor atoms were arranged in a specific way to create artificial ‘quantum 
wells’; electrons passing through this potential were then scattered along the designed 
path. The quantum wells make it possible to control the spacing between the electronic
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energy levels systematically by adjusting the length scale over which the potential varies, 
compared to the electron wavelength [73].
The use of nanomaterials and/or nanostructures in biosensors is opening up new 
ways for signal transduction, and allowing for rapid analysis o f multiple substances. In 
one-dimensional nanostructures, every atom in the structure is a surface atom, which 
offers maximum surface-to-volume ratio. This is a major advantage, and when these ID 
nanostructures are used in the biosensors, the high surface-to-volume ratio contributes to 
an increase in sensitivity [74]. Another key advantage of using nanostructures is the 
possibility to integrate a large number of devices on a single small chip [75]. Here is a 
brief review of the different kinds of nanostructures used in the biosensors.
9.3.1 Nanoparticles
As discussed in Section 9.2.1, quantum dots have been used as replacements for 
conventional fluorophores in optical biosensors because they can produce stronger 
fluorescent signal and increase the sensitivity. Quantum dots are also a good choice for 
newer optical techniques like FRET. A thin layer o f gold nanoparticles coated on the 
nano pore structure of a Fabry-Perot interferometer significantly enhances the optical 
signal due to the localized surface plasmon resonance effect [58]. Gold nanoparticles can 
also be used as fluorescence quenchers (energy acceptor) in an optical biosensor to detect 
specific DNA sequences [76]. Colloidal gold has more surface area, and when used in an 
electrochemical DNA biosensor, it enhances the amount o f immobilized DNA, which in 
turn lowers the detection limit of the biosensor [77]. Cell separation techniques use 
magnetic nanoparticles to label the cells, and then by applying magnetic field gradients, 
cells can be isolated and manipulated [78]. Paramagnetic particles make an interesting
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choice in immunoassay techniques. These particles do not require chemical or 
electromagnetic stimulations, and they can cause perturbation in the applied magnetic 
field that can be easily detected with suitable electronics [79].
9.3.2 Nanowires
Nanowires can be classified as metallic or semiconducting. Nanowires exhibit 
highly reproducible electrical [80], [81] and optical properties [73], and hence, provide 
unique opportunities to develop novel biosensors. Metallic nanowires can be grown in 
porous alumina templates [82], [83]. Semiconducting nanowires can be grown either 
using the top-down approach or the bottom-up approach [84]—[86]. Among 
semiconducting nanowires, silicon nanowires are more commonly used since they are 
easier to fabricate. Existing technologies used to fabricate microelectronics are all based 
on silicon and can be easily applied in the fabrication of silicon nanowires. Other 
semiconducting nanowires made out o f ZnO also show the ability to detect bio molecular 
interactions [87]. The high surface-to-volume ratio o f silicon nano wires has helped to 
achieve very low detection limits [88], [89]. Another advantage of using nanowire is the 
label-free nature o f the electrical detection. In most cases, the analyte molecule is directly 
detected on the surface of the nanowire through sensitive molecular interaction and no 
label is required [90], [91].
9.3.3 Carbon Derived Nanostructures
Carbon nanotube (CNT) and diamond are two widely employed carbon 
polymorphs in fabricating electrodes for electrochemical sensors [92]. Depending on the 
structure, CNTs can be classified as single-wall carbon-nanotubes (SWNTs) and multi­
wall carbon-nanotubes (MWNTs). Since every atom in a CNT is a surface atom, they
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form an ideal class o f ID nanostructures that could exhibit ideal sensitivity at the single 
molecule level [46]. Transfer o f charge from one electrode to another is a very important 
aspect in any electrochemical reaction, and it has been shown that CNTs promote 
electron-transfer reactions of proteins [47].
The biggest hurdle in using CNT for biosensors is the process involved in 
assembling the nanostructure into the sensor. The commonly used technique involves 
dispersing nanotubes in an aqueous or organic solution and then depositing them on a 
substrate. The contact electrodes are then created using electron-beam lithography. Even 
though this assembly technique is simple, the process of creating contacts is very random 
and yields a very low throughput. One of the strategies used to tackle this problem is 
based on AC dielectrophoresis. Single CNT or a bundle of CNTs can be aligned between 
a pair o f contact electrodes by controlling the time, voltage, and frequency of the applied 
AC voltage [93]. Another alternative is to use catalyst seeds at predefined locations [94]. 
However, there is still no established standard process to the assembly o f single CNT. 
Instead, it is easier to produce a network of carbon nanotubes (thin film) that involves the 
use of chemical vapor deposition (CVD) and does not require any catalyst seed. A 
network of CNT has been used in label-free detection of DNA hybridization [95]. The 
sensitivity of these devices is lower due to an increased number of CNTs, but it is 
possible to produce devices on a large scale [46].
The excellent biocompatibility, low background current, wide potential window, 
and good chemical stability make the diamond the best known electrochemical transducer 
[96]—[98], A diamond is chemically inert and shows the strongest bonding stability to 
DNA [99]. Even though a diamond possesses all these excellent properties, it has
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struggled to expand its applications in life sciences, the primary reason being the high 
costs of production and refinement [92].
9.4 Carbon Nanotube
Polymorphism, or allotropy, is a characteristic of a material that can have more 
than one crystal structure. Carbon has three important crystalline allotropes: diamond, 
graphite and buckminsterfullerene. Diamond and graphite were the best-known allotropes 
of carbon until 1985 when buckminsterfullerene (called the ‘buckyball’) was discovered 
by Robert F. Curl, Harold W. Kroto and Richard E. Smalley [100]. They were awarded 
The Nobel Prize in Chemistry in 1996. The buckminsterfullerene molecule has a total of 
60 carbon atoms (also known as C6o) and can be imagined as a soccer ball, with each 
vertex on the seam replaced by a carbon atom as shown in Figure 9-4.
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Figure 9-4: A buckyball structure with carbon atoms at every vertex o f an imagined 
soccer ball. The red lines indicate single bond and yellow lines indicate 
double bond [102].
The buckminsterfullerene crystal is a semiconductor and it exhibits
superconductivity when it forms a compound with alkali metals at low temperatures.
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Along with diamond, graphite and fullerene crystals, carbon also exists in other 
crystalline forms and structure. Amorphous carbon has no crystal structure, but it is 
defined as a structural allotrope. Carbon nanotube is another such structural allotrope of 
carbon that was discovered in 1991 by Iijima [101]. The structural allotropy in carbon is 
related directly to the different hybridization that carbon atoms can assume. A diamond is 
formed when the four valence electrons are shared equally (sp3 hybridization).
In graphite, three electrons are equally shared (sp2 hybridization) and the fourth 
electron is allowed to remain delocalized among all atoms. The sp2 hybridization results 
in a structure that has strong in-plane bonds and weak out-of-plane bonds; this is the 
reason why graphite can slide along the planes and is considered a soft material. 
Fullerenes and nanotube structures o f carbon are also formed due to sp2 hybridization. 
Under normal ranges o f pressure, bulk graphite is thermodynamically stable even at high 
temperatures, but its behavior changes when the size o f the crystal is very small. For a 
very small size, the number of carbon atoms is finite and the density o f dangling bond 
atoms is high. To become energetically stable, these atoms close onto each other to 
remove the dangling bonds. When the number of carbon atoms is less than a few 
hundred, the structures formed correspond to linear chain, rings and closed shells 
(fullerenes) [100].
9.4.1 Structure of Carbon Nanotube
According to Euler’s principle, one needs exactly 12 pentagons to close a 
hexagonal lattice completely with a topological curvature; hence, for a 
buckminsterfullerene (C6o) molecule, there are always 12 pentagons and many hexagons 
(C2n has n-10 hexagons). Carbon nanotubes are greatly elongated fullerenes and can be
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produced with 12 pentagons and millions o f hexagons. As shown in Figure 9-5, a carbon 
nanotube (CNT) is a long cylinder made o f the hexagonal lattice of carbon bound by two 
half-hemispherical fullerenes at the ends. The diameter o f the tube will depend on the 
size of the half-hemispherical fullerene. The cylindrical open-ended structure o f the tube 
can be conceptualized as rolling a sheet of graphene (single layer o f graphite) to form a 
seamless match between the open edges. On the curved surface of the tube, the hexagonal 
arrays o f carbon atoms wind around in a helical fashion introducing helicity to the 
structure. To close the ends o f the tube, pentagons are nucleated at some stage in the 
growth process.
Figure 9-5: The basic cylindrical structure o f a carbon nanotube with both ends 
closed by semi-hemispherical buckyball [103].
There are two structural variations found in nanotubes. The first, called the multi­
walled carbon nanotube (MWNT) were discovered first and are made of concentric 
cylinders placed around a common central hollow. The diameters of these tubes vary
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from 2 to 25 nm, and the distance between each cylinder is 0.34 nm. The second, called 
the single-walled carbon nanotube (SWNT), are single-layer cylinders extending from 
end to end with diameters from 1-2 nm [92]. Rolling a graphene sheet into a carbon 
nanotube can be done in several ways as long as the dangling bonds on both edges are 
matched. This process introduces chirality in carbon nanotubes, and a lattice vector Ch 
uniquely specifies the fiber diameter and chirality
Ch =  4- n 2a 2 = (n x,n 2). Eq. 9-2
Where m, ri2 are integers and aj, a2 are the unit vectors. To understand chirality, 
let us consider the scenario depicted in Figure 9-6.
Figure 9-6: A carbon nanotube formed by rolling a sheet o f graphene. The chiral 
angle is denoted by 6, ai and ci2 are the graphene unit vectors [103].
The chiral vector Ch connects two sites A and A/ on the one-dimensional graphene 
crystal. Connecting together points A and A / form the nanotube and the lightly dotted 
lines that are perpendicular to Ch show the cylinder joint. If a — 1.42 x V3 A0 is the 
lattice constant, the fiber diameter d  is then defined by
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d =
|Ch | ayjn \ + n xn 2 +  n | Eq. 9-3
71 71
therefore the chiral angle that defines the direction o f the lattice vector is given
by
0 =  arctan Eq. 9-4
(2%  + n 2)
The lattice vector Ch offers a range of orientation for carbon nanotubes ranging 
from zigzag direction [0 = 0° or (n, 0)] to armchair direction [0 = ± 30° or (n, n)] and 
hence these nanotubes are called zigzag nanotubes and armchair nanotubes, respectively, 
in Figure 9-7. All the other types of nanotubes are simply referred to as chiral nanotubes.
(a) Armchair fiber (b) Zigzag fiber
Figure 9-7: Arrangement of carbon atoms in armchair carbon nanotube (left) and zigzag 
carbon nanotube (right) [104].
9.4.2 Electronic Structure o f Carbon Nanotube
CNTs have unique electrical properties due to their chirality. Armchair nanotubes 
are metallic, whereas the zigzag and chiral nanotubes are either metallic or 
semiconducting [103]—[105]. Figure 9-8 shows how the unit vectors can be configured to 
create a metallic or semiconducting nanotube.
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Figure 9-8: Possible vectors for chiral nanotubes. Circled dots and dots represent 
metallic and semiconducting nanotube respectively [103].
The interesting properties o f CNTs are associated to their ID shape along with sp2 
and n bonding between the carbon atoms. In graphite, the electronic bands are formed 
because the it electrons between two adjacent layers are free to move between the bonds. 
The finite tube circumference of carbon nanotubes restricts the number o f possible 
electron states and a band gap opens up at the Fermi energy. The density o f states 
represented as unit of states per unit cell of 2D graphite for two different zigzag 
nanotubes (m, m) = (10, 0) and (9, 0) is shown in Figure 9-9.
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Figure 9-9: Density of states for a) zigzag nanotube (10, 0) and b) zigzag nanotube 
(9, 0). The dotted line shows density of states of 2D graphite [103].
The singularity arising due to ID structure is apparent at the edge o f every energy 
level. For the nanotube with m= 10, there is an energy gap at the Fermi Level (E=0), but 
for the nanotube with ni= 9 there are finite density of states. This shows that metallic and 
semiconducting nanotubes can be fabricated by just changing the diameter o f the tube. 
The condition for the nanotube to be metallic is
2nx + n 2 = 3q , Eq. 9-5
where q is an integer.
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The relationship between the band gap (Eg) and the diameter o f a semiconducting 
CNT is given by
Es = f  Eq.9-6
For metallic CNTs (m / m ) there exists a second band gap. This band gap is related to the 
diameter of the tube as follows [106]:
£a = T  Eq.9-7
The resistivity of a material depends on the number o f charge carriers and the 
scattering these charge carriers experience inside the crystal. In well-fabricated carbon 
nanotubes, the electrons can travel over distances of up to several micrometers without 
getting scattered (ballistic transport) [107], [108]. When carbon nanotubes are integrated 
into the devices, the contact resistance between the tube and the metal electrode becomes 
very important. The work function variation from one metal to another is very large; 
depending on the type of metal used, the contact resistance shows different behavior. 
Metals like Ti and Pd lead to p-type conducting behavior, while Mg contact electrodes 
show ambipolar characteristics. Contacts made out of Ca mostly show n-type conduction 
behavior. The values o f contact resistance can be calculated theoretically using the first 
principle; these calculations show that contacts made out o f Ti have the lowest resistance 
with CNTs followed by Pd, Pt, Cu, and Au.
9.5 Carbon Nanotube Based Immunosensor
An immunosensor is a special type o f biosensor that exclusively monitors the 
antibody-antigen interaction [109]. An immunosensor can be a direct or an indirect type 
o f sensor. In a direct immunosensor, there is a direct detection o f the antibody-antigen
73
reaction with or without the use of labels. For an indirect immunosensor, the biological 
reaction takes place in a reaction tube and a sensor measures the product o f that reaction. 
Carbon based biosensors are commonly used because o f their low cost, good electron 
transfer kinetics and biocompatibility. Carbon nanotubes display high mechanical 
strength, chemical stability and electrical conductivity, which make them ideal for use in 
the sensors.
The electrochemical signal generated from an antigen-antibody interaction in a 
CNT based immunosensor can be detected in two ways [110]. The first strategy is based 
on building a CNT based field-effect transistor (FET). The typical procedure involves 
binding the antibody to the CNT and then allowing the antigen to interact with the 
antibody. The electrochemical signal generated due to the antigen-antibody interaction 
changes the electric field, which in turn modulates the drain current o f the transistor. The 
second approach is an indirect detection method where, just like the first strategy, an 
antibody is attached to the CNT and the antigen, then binds to the antibody. The CNT is 
then exposed to a second antibody that has a tag that is either redox active or can 
facilitate electrochemiluminescence. The label-free approach o f the first strategy is more 
appealing and extensively utilized in modem biosensors.
9.5.1 Field-Effect Transistor (FET) Based Immunosensor
The use of silicon as a substrate in electrophysiological measurements was started 
in the late sixties at Stanford University [111]. In 1970, Bergveld introduced the idea of a 
solid-state device that could measure ion-concentrations in electrochemical and 
biological environments [112]. Besides measuring the electrical potential, this device 
could measure the ion concentrations, and it was called an ion sensitive field effect
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transistor (ISFET). The ISFET is a special type o f MOSFET. As shown in Figure 9-10 
instead of a conventional gate found in a MOSFET, the gate in an ISFET is a reference 
electrode that is inserted in an aqueous solution that is in contact with the gate oxide.
Figure 9-10: Construction of a) conventional MOSFET and b) ISFET proposed by
The ISFET became popular after its invention in 1970, so much so that in the next 
thirty years it accounted for more than 600 papers on the subject and inspired the 
development of many other devices, such as EnzymeFET (ENFETs), ImmunoFETs 
(IMFETs), etc. [113].
After the discovery o f CNT in 1991, the semiconducting and metallic nature of 
CNT was extensively studied in the early 90s. The field-effect behavior in CNT was first 
reported from a metallic CNT operated at very low temperatures [114], whereas the first 
transistor fabricated with a single semiconducting CNT operating at room temperature 
was reported later in 1998 [115]. The ability o f this transistor to operate at room 
temperature opened the door for various applications in the following years. The first 
CNT based transistor reported by Tans et al. is shown in Figure 9-11. The gate is a 
silicon wafer with a 300 nm thick layer o f silicon oxide. The single semiconducting CNT
o
Reference
electrode
Source Source Drain
MOSFET ISFET
(a) (b)
Bergveld [113],
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between the two Pt electrodes was produced by condensation of laser-vaporized carbon- 
nickel-cobalt mixture at 1200° C [116].
Pt Si02 Pt Si02
Figure 9-11: a) AFM image of single CNT on top of three Pt electrodes b) schematic 
side view of the transistor [115].
A detailed study o f CNT based FET revealed the transport in CNTs is dominated 
by holes at room temperature and the transistor exhibits p-type behavior [117]. To get the 
output characteristic, the source-drain voltage was swept from -200 mV to +200 mV with 
gate voltages o f Vg = -6, 0, 1,2, 3 ,4 , 5, and 6 V. The output characteristic is shown in 
Figure 9-12a. The transfer characteristic was obtained by sweeping the gate voltage and 
incrementing the drain-source voltage from 10-100 mV in the steps of 10 mV. As shown 
in Figure 9-12b, the conductance o f the transistor can be modulated with the gate 
electrode. This study suggested that the SWNCT-FET behaved liked an ordinary FET, 
but it was later proven that it is the Schottky barriers at the CNT-metal contacts that play 
a central role in modulating the conductance o f the transistor [118]—[120].
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Figure 9-12: a) Output characteristic and b) transfer characteristic of SWCNT-FET 
[117].
A Schottky barrier, as shown in Figure 9-13, is a potential energy barrier created 
when a metal and semiconductor are brought in contact. The Schottky barrier height, O b , 
is the difference between the interfacial conduction band edge Ec and Fermi level £>-. The 
metal-semiconductor contact can behave as a rectifier (electrons flow only in one 
direction) or as a resistor (electrons can flow in both directions) depending on the 
barrier’s height. If the barrier is high enough, a depletion region is formed and the contact 
is a rectifying type, whereas if the barrier is low, the contact is ohmic (acts as a resistor). 
At the start o f the century, it was demonstrated that the surface adsorption o f various 
molecules and the change in their electrostatic charges vary the conductance of a
Vso=100mV «  ]fr-
010-10
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nanotube significantly [121]—[123], This opened up the avenue for using SWCNT-FET 
for biomolecule detection.
Semicon.
E-p —
Figure 9-13: Formation of Schottky barrier at metal-semiconductor junction for zero 
bias [124],
9.5.2 Sensing Mechanism in SWCNT-FET Based Immunosensor
The exact sensing mechanism in SWCNT-FET based immunosensor was a topic 
of debate [125]. The initial work on SWCNT-FET as an immunosensor included 
detection of protein A and biotin-streptavidin [126], [127], and it suggested the 
conductance of the CNT transistor changed due to the electrostatic gating. The various 
functional groups present in proteins lend them surface charges, and these charges exert 
electrostatic gating to alter the carrier density in the nanotubes [126]. A more detailed 
study later suggested that the region near the edge o f the nanotube-metal contact 
(Schottky Barrier effect) was the dominant sensing region and was more sensitive to 
charge on the absorbed protein [128]. An ultrasensitive immunosensor fabricated by 
modifying the geometry o f CNT-metal contact is capable o f detecting proteins as low as 
1 pM [129],
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Work done on DNA sensors also suggests that the modulation o f the Schottky 
barrier at the metal-CNT contact by efficient hybridization is the dominant sensing 
mechanism [130], [131]. However, Dekker et al. has concluded that the sensing in an 
SWNT-FET based immunosensor is dominated by a combination of electrostatic gating 
effect and Schottky barrier effect, where the electrostatic gating is more reliable along the 
bulk o f the SWCNT [132]. To prove the electrostatic gating was more reproducible, they 
carried out experiments with two types of devices: one with the passivized CNT-metal 
contacts to eliminate the chance of Schottky barrier effect, and the other with non­
passivized CNT-metal contacts, which allowed the Schottky barrier effect. The behavior 
o f the device with non-passivized metal-SWCNT contact before and after the protein 
adsorption is shown in Figure 9-14. The electrostatic gating shifts the semiconducting 
bands downwards after protein adsorption (indicated by the red curve). The Schottky 
barrier effect alters the difference between the metal and SWCNT workfunctions.
b. Schottkya. Gating
Figure 9-14: The black curve corresponds to device characteristic before protein 
adsorption and the red curve corresponds to the device characteristic 
after protein adsorption a) electrostatic gating effect b) Schottky barrier 
effect [132],
Since most o f the biomolecules, including proteins, are suspended in
physiological buffer solutions, the interface between the solution and the charged surface
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of a sensor plays a vital role in detection [133], [134]. When a charged surface comes in 
contact with an ionic solution (electrolyte), the oppositely charged ions in the solution are 
attracted towards the surface-electrolyte interface and form an electrical double layer 
(EDL) as shown in Figure 9-15. The distance from the interface where the electrostatic 
field strength has dropped to 1/e o f its initial value defines the thickness o f this electrical 
double layer. This distance is also called the Debye screening length, k ', and its value is
■ - - p .
where q is the elementary charge, k is the Boltzmann’s constant, T is absolute 
temperature, eO is the permittivity of vacuum, e is the dielectric constant, and /  represents 
the ionic strength. For 1 -1 salt I  can be replaced with the concentration of ion (c). For 
most o f the physiologically relevant buffer solutions with ionic strength o f ~ 100 mM, the 
Debye length k 1 is around 1 nm and the surface potential is completely screened at a 
distance o f a few nanometers away from the interface. So to successfully detect a protein 
adsorbed on the SWCNT surface, the dimensions of the protein have to be less than lnm. 
Normally, the dimensions of the proteins are much larger (around 10 nm), so to tackle 
this problem, most of the sensors based on SWCNT or nanowires are operated in buffers 
with low ionic strength (~1 nM to 10 mM) [80], [132], [135], [136].
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Antibody
Antigen
Figure 9-15: Schematic representation of electrical double-layer and the antibody 
adsorbed on the interface [137].
9.6 Protein Immobilization
Immobilization can be defined as the attachment o f bio molecules to a surface, 
which results in the reduction or complete loss of mobility. To achieve good reproducible 
selectivity and sensitivity in an immunosensor, it is crucial that the antibody molecule is 
bound to the transducer surface in a highly controllable way and is oriented in a way that 
is optimal for the specific antigen binding without affecting its activity [138]. The 
orientation o f the antibody should be such that the binding site of the protein is optimally 
accessible for the target antigen. The immobilization techniques are mainly based on the 
following three mechanisms: physical, covalent, and bio-affinity immobilization [139].
9.6.1 Physical Immobilization
Physical adsorption is the simplest and most inexpensive method to immobilize 
proteins. The adsorption occurs due to the weak interactions between a protein and the 
surface; factors like hydrogen bonds, electrostatic interactions, hydrophobic interactions, 
and Van der Waals interactions are responsible for adsorption. This technique is simple
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and involves incubating the substrate in a protein solution followed by the rinsing off of 
the non-adsorbed protein. The drawbacks o f this technique include random orientation 
and weak attachment as some buffers or detergents may wash off the protein during the 
assay.
9.6.2 Covalent Immobilization
A more robust way to immobilize proteins on the surface is by means of covalent 
bonds. This technique requires the presence o f two mutually reactive chemical groups on 
the surface o f the substrate and the protein. The functional group on the surface o f the 
substrate is generated by chemical treatment and the covalent bonds are formed between 
the exposed side-chain functional groups o f the protein and the modified surface 
substrate. Table 9-1 shows the required functional groups on the surface o f the substrate 
corresponding to the available groups on the protein [139].
Table 9-1: Commonly available functional groups in proteins and functional groups 
required on the substrate surface.
Side groups Amino acids
Functional groups required on the 
substrate surface
- n h 2 Lys, hydroxyl-Lys Carboxylic acid Active Ester (NHS) 
Epoxy 
Aldehyde
-SH Cys MaleimidePyridyil disulfide 
Vinyl sulfone
-COOH Asp, Glu Amine
-OH Ser, Thr Epoxy
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9.6.3 Bio-affinitv Immobilization
This technique is based on complementary affinity interactions between 
biomolecules and generates a well-oriented and homogenous attachment o f the antibody. 
It is also possible to detach proteins and make repeated use o f the same surface. The 
commonly used techniques include Avidin-Biotin system, His-Tag system, DNA-directed 
immobilization, and Protein A/Protein G-mediated immobilization. The Protein A/Protein 
G-mediated immobilization relies on the specific interaction of the Protein A/Protein G 
with the Fc constant region of the Immunoglubolin G (IgG) molecule. The basic structure 
of IgG is shown in Figure 9-16. The first step in this technique is to immobilize the 
Protein A/Protein G covalently on the surface o f the substrate. Next, the antibody (IgG) is 
introduced; the specific bio-affinity o f Protein A/Protein G to the Fc region orients the 
IgG such that the binding sites o f the IgG remain easily accessible for binding with the 
antigen.
HOOC COOH
Figure 9-16: Structure o f IgG where 1) Fab region, 2) Fc region, 3) heavy chain, 4) 
light chain, 5) antigen binding sites, 6) hinge regions [140].
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9.7 Carbon Nanotube Thin Film
As discussed in Section 9.3.3, individual carbon nanotubes have a very large 
surface-to-volume ratio and can act as an ideal sensor. Every atom in the nanotube is on 
the surface acting as an individual sensing site; hence, it is possible to achieve single 
molecule detection. However, there are many challenges that prevent a carbon nanotube 
based sensor from operating at ideal levels [46]. One major challenge is to passivize the 
contacts of a sensor based on a single carbon nanotube. Contact passivation is critical for 
sensors to detect an analyte directly in a liquid. Sensing can be achieved without contact 
passivation, but then the response will be dominated by the receptors immobilized on the 
contacts [130], [131].
In most o f the CNT based sensor prototypes, the contacts are passivized using E- 
beam lithography, but alternate techniques must be used to be competitive with 
conventional sensors. The length of a carbon nanotube becomes a limiting factor when 
techniques like photolithography or nano imprint are used. The high sensitivity o f CNT 
based sensors is established on the fact that every atom of the single CNT acts as an 
individual sensing site. Normally, CNTs tend to form bundles, or networks, and the 
sensitivity can drop drastically if  the sensor cannot be built out of a single CNT. Sensors 
based on a single CNT should be reusable to remain competitive.
Repeated use leads to accumulation of analyte species on the surface and 
produces drifts that affect the reproducibility of the sensor. One way to tackle this 
problem is to have some kind of on-site cleaning mechanism on the chip; the other easier 
approach is to use disposable chips. For sensors based on ID structure like CNT, there 
are notable variations in device characteristics. Due to these variations, it is very
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important to calibrate each sensor before use. It is thus a major challenge to develop a 
reusable CNT based sensor that can be calibrated easily before deployment in a real-life 
scenario. A thin film made out o f carbon nanotubes can be a good alternative to 
overcoming most o f these challenges while sacrificing only some of the sensitivity.
A carbon nanotube thin film (CNTF) can be regarded as a novel material that has 
a 2D network o f randomly distributed CNTs [141]. This thin film can either be a 2D 
network of vertically oriented carbon nanotubes [142] or o f a horizontally laid network of 
nanotubes. A CNTF is usually a mixture of metallic and semiconducting CNTs, which 
makes CNTFs exhibit semiconductor-metal transition with increasing film thickness 
[143], [144]. The semiconducting behavior of CNTF in thin film transistor and sensor 
applications is observed when the density o f CNTs is closer to the percolation threshold 
[145], [146], [147]. Porosity in thicker CNTF (usually micrometer thick) is an advantage 
in fuel cells and battery applications [148], [149], CNTF with intermediate thickness, 
ranging from 10-100 nm, shows high optical transparency and electrical conductivity 
[150],
9.7.1 Fabrication of CNTF
There are two broad categories o f CNTF fabrication: Direct growth methods and 
solution-based coating methods.
9.7.1.1 Direct Growth
The three major methods to fabricate CNTs are: arc-discharge, laser ablation, and 
chemical vapor deposition (CVD). CVD is the most widely used method to grow CNTF 
with randomly distributed or aligned nanotubes. Aligned nanotubes are central in devices 
exhibiting high mobility, and they also make it possible to realize molecular electronics,
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but these devices suffer from poor statistical reproducibility [141]. As compared to films 
made out of aligned nanotubes, CNTF made out of randomly distributed CNTs are more 
reproducible and hence can be used in more practical applications [151]. The high 
vacuum and high temperature involved in direct methods like CVD may not be 
compatible with many substrates that are being used in the emerging plastic electronics 
field. Direct methods like CVD are, however, able to produce tubes with fewer detects 
and better CNT-CNT contacts that can lead to highly conductive films.
9.7.1.2 Solution-based Deposition
Solution-based deposition methods offer several advantages over direct growth 
methods. These methods are carried out at low temperatures, do not require a high 
vacuum, and are compatible with a wide range o f substrates. The quality o f the thin film 
depends on several factors including CNT material quality, stability o f CNT dispersion, 
adhesion quality, and stability on the substrate. Solution-based deposition is a two-step 
process: a) preparing a stable CNT dispersion and b) coating the dispersion on the 
substrate.
9.7.1.2.1 Stable CNT Dispersion
The biggest challenge in fabricating CNTF is to prepare a stable dispersion of 
CNTs. The large aspect ratio o f CNTs results in strong Van der Waals forces, which 
cause them to stick together and form large bundles. There are four major dispersion 
methods used in CNTF production: a) use of surfactant, b) use o f polymers, c) use of 
organic solvents and water to fiinctionalize CNTs, and d) use of DNA, protein, and 
starch.
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Using surfactant to disperse CNTs is the most commonly used dispersion method 
[152], Any surfactant works by attaching its hydrophobic end to the CNT and pulling the 
CNT into a water-like solvent with its hydrophilic tail. A surfactant can be anionic 
(produce negative charge in water), cationic (produce positive charge in water) or 
nonionic (neutral in water). Triton X-100, sodium dodecyl sulfate (SDS), and sodium 
dodecylbenzene sulfonate (NaDDBS) are the most widely used surfactants [153],
Polymers are commonly used in applications which make use o f CNT- polymer 
composites [154], [155]. They interact nondestructively with pristine CNTs and maintain 
their intrinsic properties. Polymers are not preferred in thin film applications due to their 
large size and difficulty to remove them after fabrication.
The biggest advantage of using organic solvents to disperse CNTs is the minimal 
amount of residue found in the final film. The Hansen solubility parameters define the 
dispersion state. There are two forces involved when using organic solvents: a) the 
attractive Van der Waals forces between CNTs and b) the interactions between the CNTs 
and the solvent. Tour et al. have found that the best solvents for dispersing CNTs are 1,2- 
dichorobenzene, chloroform and N-methypyrrolidinone [156].
Using DNA and proteins to disperse CNTs are common in biological applications. 
Dispersion o f CNTs in water is highly desirable as it is environmentally friendly and 
biocompatible. One way to functionalize CNTs is to treat them with extreme acids that 
makes it possible to disperse CNTs in water [157].
9.7.1.2.2 Coating Methods
Once the stable CNT dispersion is made, the next significant challenge is to 
uniformly lay down the CNT dispersion on the substrate and dry the solution without
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causing agglomeration. There are many methods that are used to achieve the uniform 
coating o f CNTs on the substrate.
The Langmuir-Blodgett (LB) method, also known as “logs-on-a-river” concept is 
based on the hydrophobic nature o f CNTs [158]. The first step in this method is to 
disperse the CNTs over the surface of the water; next, the substrate is dipped in the 
dispersion and withdrawn horizontally or vertically. This method requires a precise 
control over the process, or else the film is easily broken. The other disadvantage is the 
time required to achieve more than a monolayer.
The self-assembly (SA) method depends on the interaction between the CNTs and 
the substrate. CNTs will adhere to the surface depending on the chemical groups 
available on the surface of the substrate. The surface can be modified with chemicals or 
by creating local charges [159], [160]. The chemical functionalization can make use of 
either polar groups such as amino (-N H 2) or carboxyl ( -  COOH), or nonpolar groups like 
methyl (-C H 3) to modify the substrate. When such a functionalized pre-pattemed 
substrate is immersed in the dispersion, the CNTs are attracted to the exposed groups on 
the patterns and self-assemble to produce the final pattern. One can also scale up the 
process by using this in conjunction with photolithography.
The electrophoretic deposition (EPD) method uses a DC electric field to deposit 
CNTs. In this method, a low DC electric field is applied to a conductive substrate the that 
helps the CNTs to align themselves linearly and deposit on the electrode [161]. Another 
method that employs an electric field to deposit CNTs is Dielectrophoresis (DEP). DEP 
uses an AC electric field to deposit and separate CNTs at the same time [162],
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The deposition methods used in the industry involve depositing the dispersion on 
the substrate, followed by controlled drying. There are several methods to deposit the 
solution on the substrate, which include Mayer Rod, Slot Die, and Gravure [163], [164].
9.7.2 Patterning Carbon Nanotube Thin Films
Most o f the applications using CNTF require some kind of patterning on the films 
to get the desired geometry. For direct growth methods like CVD, a CNT film will grow 
only where the catalyst is deposited [165], [166]. So to get a patterned CNTF using direct 
growth, the catalyst must be strategically deposited at the patterned sites. Other methods 
including photolithography, inkjet printing, and micro contact printing can also be 
utilized to pattern the catalyst.
There are two types of solution-based pattern deposition methods: additive and 
subtractive. The additive methods are bottom-up approaches that use techniques like 
inkjet printing, patterned filtration, and microfluidic channel guided coating [167]—[169]. 
Subtractive methods are top-down approaches that use techniques like photolithography, 
or E-beam lithography, to print a pattern on the thin film, followed by plasma etching or 
laser ablation to remove the CNTs from the unprotected part o f the film [170], [171]. 
Plasma of Ar, O2, CF4 or CF6 can effectively etch carbon nanotubes. Another interesting 
technique to grow patterned thin films combines photolithography and layer-by-layer 
self-assembly [172]—[174], The patterns are generated using the conventional 
photolithography approach; the substrate is then sequentially dipped into a solution 
containing charged CNTs, followed by a solution that has an opposite charge o f the CNT 
solution.
89
The choice o f patterning methods depends on the type o f substrate, the desired 
resolution, and the cost. Subtractive methods, like plasma etching or laser ablation, yield 
higher throughput for large-scale device application. High-speed inkjet printing is a very 
promising additive technique for large area patterning.
9.7.3 Electronic Properties o f Carbon Nanotube Thin Films
The CNT’s are not aligned for most o f the fabrication techniques used to create 
single-walled carbon nanotube thin film (SWCNTF). Due to the interconnected nature of 
CNT’s within the film, a Schottky barrier is created at the junction between two CNTs. 
This lack of alignment and existence of a Schottky barrier can produce SWCNTF with a 
wide range of electrical conductivity. The electrical conductivity o f pure (not 
functionalized) SWCNTF ranges from 12.5 S/cm [175] to -10000 S/cm [176].
The conductivity of SWCNTF shows a strong dependence on the film’s thickness 
and there is a sharp increase in conductivity beyond a certain thickness. This type of 
behavior is a characteristic of percolating network. The percolation threshold (pc), the 
conductivity (D), the critical exponent (0), and the concentration of conducting channels 
ip) are related as
it oc (p — pc) “ . Eq. 9-9
Bekyarova et al. demonstrated that, at room temperature, the conductivity data for 
their films fits directly to the film thickness (t) according to Eq. 9-9 [144]
a r t  w ( t  -  t c) a, Eq. 9-10
where t and t< are the film thickness and critical thickness (percolation thickness), 
respectively, and D is a critical exponent. They also found that for non-functionalized 
films, the conductivity saturates beyond a certain thickness. In their case, this thickness
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was t ~  50 nm. For non-covalently functionalized films, the conductivity was an order of 
magnitude lower than the non-functionalized films, whereas the conductivity of 
covalently functionalized films was two orders of magnitude lower than the non- 
functionalized films. They also observed the percolation threshold for functionalized 
films (both covalent and non-covalent) were higher compared to non-functionalized 
films. Functionalization introduces increased tunneling barriers between the SWCNTs, 
and according to percolation theory, the introduction of insulating substituents dilutes the 
concentration of the conducting pathways. This is the reason why the conductivity 
decreases and the percolation threshold increases for functionalized SWCNTF.
9.8 Layer-by-Layer Self-Assembly
The layer-by-layer (LBL) technique is a self-assembly process introduced in the 
early part o f the 19th century to prepare polyelectrolyte multilayers [177], [178]. This 
bottom-up technique is based on the electrostatic adsorption of charged molecules or 
nanoparticles and can be used to achieve some unique geometries and functionalities 
[179]—[182]. The solution based molecules or nanoparticles can be assembled on any 
substrate, and the entire assembly process can be carried out in a normal laboratory setup.
A thin film of inorganic nanoparticles assembled by LBL technique is basically 
formed by alternate adsorption o f a polyelectrolyte and the inorganic nanoparticle on the 
substrate. Every cycle in the assembly process to create one layer consists o f two steps: 
incubation and rinse. As shown in Figure 9-17, the charged substrate is immersed into an 
oppositely charged polyelectrolyte solution and incubated for a certain time. The 
incubation is then followed by a deionized (DI) water rinse, and sometimes an additional 
drying step may be added. During the incubation step, the oppositely charged
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polyelectrolyte electrostatically absorbs on the substrate and modifies the original charge 
on the substrate, and the subsequent rinse removes the excess polyelectrolyte from the 
substrate. Often, to facilitate the production o f thin film assembly, a precursor layer is 
assembled prior to the deposition o f the inorganic nanoparticle. This precursor layer is 
composed of one or two bilayer of polyelectrolyte and plays a very vital role in the 
efficiency of the assembly and the time required to assemble the film with a desired 
thickness [183].
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Figure 9-17: Schematic representation o f electrostatic LBL assembly.
CHAPTER 10
FET BASED BIOSENSOR: DESIGN, MATERIALS, AND 
EQUIPMENT NEEDED FOR FABRICATION
10.1 Design
Two types o f devices were fabricated as shown in Figure 10-1 and Figure 10-2. 
The type I device has three electrodes: source, drain, and gate, while the type II device 
has only two electrodes: source and drain. The type 1 device was fabricated to verify that 
the device exhibited a FET-like behavior, while the type II device was used to detect the 
biomolecules. Two masks are required to fabricate the type I device. The first mask is to 
pattern the source and drain contact electrodes on the silicon wafer, and the second mask 
is to pattern the channel between the two electrodes. The type II device utilizes both of 
the masks used in the fabrication of the type I device and requires an additional mask to 
fabricate the gate electrode. All three masks were first designed in AutoCAD and then 
converted to the proper GDSII format to feed into the mask writer.
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c
Figure 10-1: a) Schematic top view o f type I device, blue circle highlights the
channel region b) zoom-in view of the channel region highlighted by 
blue circle c) schematic top view of type II device. The CNTF in the 
channel is not shown here.
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Figure 10-2: a) Schematic cross-sectional view of type I device and b) schematic 
cross-sectional view of type II device. The type I device has three 
electrodes: source, drain, and gate, while the type II device has only the 
source and drain electrodes.
10.2 Materials
The materials and equipment needed in this project are divided based on the 
research cycle: fabrication, characterization, and finally, biomolecule detection.
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10.2.1 Materials Used for Fabrication
The device fabrication in this project uses photolithography techniques in 
conjunction with LBL self-assembly. The following is a list of wafer cleaning chemicals, 
photoresists, photoresist developer, and other chemicals used to fabricate the device.
10.2.1.1 Silicon Wafers
The silicon wafers were purchased from Silicon Valley Microelectronics, Inc. 
Some of the important wafer specifications are: diameter: 100+/-0.5 mm, orientation: <1- 
0-0>+/-l°, type/dopant: N/As, resistivity: 0.002-0.004 ohm-cm, and film: 2000 A +/-5% 
thermal oxide.
10.2.1.2 Ammonium Hydroxide
Ammonium hydroxide assay 28-30 w/w% was purchased from Fisher Scientific.
10.2.1.3 Hvdroeen Peroxide
Hydrogen peroxide, 30% solution, was purchased from EMD Millipore. 
Ammonium hydroxide and hydrogen peroxide were used to clean the organic impurities 
on the silicon wafer.
10.2.1.4 Shipley S1813
Shipley S I813 is a positive photoresist; upon exposure to light, the interaction 
between the molecules is weakened, which makes it easy to strip off the exposed resist 
with the help of a developer.
10.2.1.5 LOR3B
Lift-off resist, LOR 3B, was purchased from MicroChem. LOR 3B when used in 
conjunction with a photoresist to create a bilayer can facilitate in a high-yield metal-lift 
off process.
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10.2.1.6 MF-319
MF-319 was purchased from DOW Chemical. MF-319 is used to develop patterns 
exposed on Shipley 1813 photoresist; it is also capable o f developing LOR 3B.
10-2.1.7 Remover PG
Remover PG was purchased from MicroChem. Remover PG is a solvent stripper 
designed to remove photoresists efficiently and completely. It was also used in the lift-off 
process as a lift-off solvent.
10.2.1.8 Nitric Acid
Nitric acid, ACS reagent 70%, was purchased from Sigma-Aldrich.
10.2.1.9 Sulphuric Acid
Sulphuric acid, ACS reagent 95-98%, was purchased from Sigma-Aldrich.
10.2.1.10 Membrane Filter
Membrane filter made of mixed cellulose ester and pore diameter 0.2 microns was 
purchased from Whatman GmbH. This filter was used to filter out the acid treated 
SWCNTs from the acidic solution.
10.2.1.11 SWCNTs Dispersion in D I Water
The SWCNTs were purchased from Carbon Solutions, Inc. A good dispersion of 
SWCNTs in DI water is very important for LBL assembly. To achieve this, 100 mg of 
these tubes were treated with a mixture o f nitric acid and sulphuric acid (1:3 ratios) at 70° 
C for 30-45 minutes on a hot plate. The tubes were then filtered out from the acid mixture 
using a vacuum filtration setup with the membrane filter. The tubes were then further 
washed several times with DI water using the same vacuum filtration setup but changing 
the membrane filter. The filtered tubes were then added to 100 mL o f DI water and
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agitated in an ultra-sonic agitator for 1 hour to produce a final dispersion of 1 mg/mL.
The pH of the final SWCNTs solution was adjusted to around eight by adding small 
volumes o f diluted N H 4O H .  The acid treatment functionalizes the SWCNT with a 
carboxyl group as shown in Figure 10-3, and imparts a negative charge on the tubes when 
dispersed in DI water. The charge on the SWCNT was measured using a zeta potential 
analyzer, and at pH = 8 the charge on the SWCNT was around -60 mV.
O O
I Ic — o c —  o
Figure 10-3: Functionalized SWCNT with carboxyl group [173],
10.2.1.12 Polv (diallvldimethvl ammonium chloride) solution
Poly (diallyldimethyl ammonium chloride) (PDDA) with structural formula as 
shown in Figure 10-4, average Mw 200,000-350,000 (medium molecular weight), 20 wt. 
% in H20  was purchased from Sigma-Aldrich. PDDA acts as the polycation needed 
during LBL self-assembly.
Figure 10-4: Structural formula for PDDA [184].
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10.2.1.13 Poly (,sodium 4-stvrenesulfonate)
Poly (sodium 4-styrenesulfonate) (PSS) powder with structural formula as shown 
in Figure 10-5, average M w -70,000, was purchased from Sigma-Aldrich. PSS acts as 
the polyanion in LBL assembly.
o=s=o
ONa
Figure 10-5: Structural formula for PSS [185].
1 0 . 2 . 1 . 1 4  Sodium Chloride
Sodium chloride was purchased from Sigma Aldrich. When NaCl is added to 
PSS, it helps to shorten the recovery regime during LBL self-assembly [183].
10.2.1.15 Other Chemicals
Acetone and Isopropyl alcohol are used to strip-off resist debris at the end o f the 
metal lift-off process and LBL assembly. Deionized (DI) water is used for rinsing the 
wafer at various times during the entire fabrication.
10.2.2 Materials Needed for Biomolecule Detection
10.2.2.1 l-Ethvl-3-r3-dimethvlaminopropvllcarbodiimide hydrochloride (EDC) 
EDC is a water-soluble zero-length carbodiimide cross-linker that activates 
carboxyl groups for spontaneous reaction with primary amines and facilitates the 
coupling between them. EDC reacts with a carboxyl to form an amine-reactive O- 
acylisourea intermediate, but if  this intermediate does not encounter an amine, it will
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hydrolyze and regenerate the carboxyl group. EDC was purchased from Thermo 
Scientific, and 10 mg o f EDC was added to 1 mL o f DI water.
10.2.2.2 Protein A
Protein A is a protein found in the cell wall of the bacterium Staphylococcus 
aureus. Protein A binds to immunoglobin G (IgG) with high affinity. Four out of the five 
domains in protein A tend to bind with the Fc region o f IgG molecule. Protein A was 
purchased from Thermo Scientific.
10.2.2.3 Immunoslubolin G (IsG)
An antibody is a Y-shaped protein as shown in Figure 10-6 that binds highly 
specifically with its corresponding antigen. In this work, rabbit IgG was purchased from 
Sigma-Aldrich.
IHr o
HOOC COOH
Figure 10-6: Structure o f IgG where 1) Fab region, 2) Fc region, 3) heavy chain, 4) 
light chain, 5) antigen binding sites, 6) hinge regions [140],
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10.2.2.4 Sea Block
Sea Block blocking buffer was used to prevent non-specific binding o f the IgG on 
the sensor surface. Sea Block buffer was purchased from Thermo Scientific.
10.3 Equipment
10.3.1 Equipment Needed for Fabrication
10.3.1.1 Hot Plate
The hot plate was used to dry the wafer after the initial cleaning step. The soft- 
bake required for the photoresist and LOR 3B are also done on a hot plate.
10.3.1.2 Spin Coater
The spin coater (manufactured by Cost Effective Equipment) was used to coat 
uniform thickness of photoresist and LOR 3B on the wafer.
10.3.1.3 U VLisht Source and Mask Aliener
SUSS MicroTec mask aligner was used to align the mask and the wafer; the wafer 
was then exposed with a UV light source.
10.3.1.4 E-beam Evaporator
The E-beam evaporator from CHA industry was used to deposit chromium (Cr) 
and gold (Au) for the contacts.
10.3.1.5 Optical Microscope
An optical microscope was used during various stages of fabrication to inspect the 
patterns on the wafer. The microscope used is Olympus Vannox AHMT3.
10.3.1.6 Vacuum Pump
Vacuum pump in conjunction with membrane filter was used to carry out vacuum 
filtration of acid treated SWCNTs.
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10.3.1.7 Ultra-sonic Asitator
The ultra-sonic agitator (Branson 2510) was used to agitate the final SWCNTs 
solution. The agitation helps to get a well-dispersed SWCNTs solution.
10.3.2 Equipment Needed for Characterization and Protein Detection
The device characterization and protein detection was carried out on a Keithley
probe station. We used a zeta-potential measuring device to investigate the charge on the 
functionalized SWCNTs; it was also used to investigate the charge on the protein A and 
IgG at different pH values.
10.3.3 Other Equipment
A micropipette is useful in dispensing the desired amount o f PBS, protein A, and 
IgG during various stages of the project. A handheld pH meter is also useful in 
investigating the pH value of the SWCNTs solution.
CHAPTER 11
FET BASED BIOSENSOR: FABRICATION
The FET based biosensor was fabricated with a combination of conventional top- 
down photolithography methods and LBL self-assembly.
11.1 Fabricating the Source and Drain Contact Electrodes
Since both the type I and type II devices require the source and drain contact 
electrodes, it was logical to begin fabricating these contacts first. All the devices were 
fabricated on a single 100 mm, p-type <100> silicon substrate. The silicon wafer has a 
200 nm thick layer of thermally grown oxide. This oxide ensures that the devices 
fabricated on the wafer are not electrically shunted at any point during the 
characterization or testing phase.
Fabrication of the source and drain contact electrodes began with cleaning the 
silicon wafer. The organic debris on the wafer was cleaned by immersing the wafer in an 
aqueous mixture of ammonium hydroxide, hydrogen peroxide, and DI water (ratio of 1:
1: 10, respectively) for 20 minutes at a temperature o f 75° C. After 20 minutes the wafer 
was taken out of the cleaning solution and first immersed in a bath o f DI water for five 
minutes, followed by a thorough rinse under running DI water for one minute. The wafer 
was dried by blowing nitrogen and then placed over the hot plate at 115° C for five 
minutes to ensure it was completely dry. As shown in Figure 11-1, to create a bilayer o f
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LOR and S1813 resist, first a 600 nm thick layer o f LOR 3B was uniformly coated on the 
wafer using a spin coater. The wafer was then soft baked at 180° C for three minutes on a 
hot plate. After a five minute cool down, a one-micron thick layer of resist SI 813 was 
coated on the wafer. It was then soft-baked on the hot plate at 115° C for 90 s, followed 
by a five minute cool down.
Spin co a t LOR and  positive 
photo  resist
E xpose th e  w afer to the  
source-drain  m ask
D evelop the  ex p o sed  w afer
E vaporate  Gold (Au)
U se R em over PG to dissolve 
the  LOR and  photo resist
Final structure: 
S ou rce  and  Drain con tac ts
■ Oxidized 
'Silicon
| S 1 8 1 3
LOR 3B
Gold (Au)
□Source-D rainM ask
Figure 11-1: Process flow to fabricate source and drain contacts for type I and type II 
devices.
To transfer the pattern o f the source and drain contact electrodes on the wafer, the 
source-drain mask was loaded into the mask aligner and then the wafer was exposed for 
11 s. The exposed wafer was developed in MF-319 developer solution for 60 s and the
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quality o f the pattern was inspected under an Olympus microscope. The undercut in the 
LOR 3B layer is very important for the lift-off process, as a good undercut ensures easy 
metal lift-off. The developed wafer was then loaded into an E-beam evaporator to deposit 
100 nm of Au. To enhance the adhesion of Au on silicon oxide, a 50 nm thick layer o f Cr 
was deposited prior to the deposition o f Au.
To perform the final metal lift-off step, the wafer was dipped in a bath o f the 
Remover PG solution heated to 60° C for three to four hours. A dip in the second bath 
greatly helped to remove the unwanted metal layer completely. After inspecting the wafer 
under the microscope, the final step was to clean the wafer in IPA and then rinse with DI 
water.
11.2 Fabricating the Gate Electrode
The gate contact electrode for the type I device was fabricated using the metal lift­
off technique. To create a bilayer o f LOR and SI 813 resist, first a 600 nm thick layer of 
LOR 3B was uniformly coated on the wafer with a spin coater. The wafer was then soft 
baked at 180° C for three minutes on a hot plate. After a five minute cool down, a one- 
micrometer thick layer o f resist S 1813 was coated on the wafer. The wafer was then soft- 
baked on a hot plate at 115° C for 90 s, followed by a five minute cool down.
To transfer the gate pattern on the wafer, the gate mask was loaded into the mask 
aligner and then the exposed for 11 s. The exposed wafer was developed in MF-319 
developer solution for 60 s and the quality o f the pattern was inspected under an Olympus 
microscope. The developed wafer was then loaded into an E-beam evaporator to deposit 
150 nm of Al.
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To perform the final metal lift-off step, the wafer was dipped into a bath of the 
Remover PG solution heated to 60° C for three to four hours. A dip in the second bath 
greatly helped to remove the unwanted metal layer completely. After inspecting the wafer 
under the microscope, the final step was to clean the wafer in IPA and then to rinse with 
DI water.
11.3 Fabricating the Channel
A combination o f photolithography and LBL assembly was used to fabricate the 
channel for type I and type II devices. The entire process flow for type II device is shown 
in Figure 11-2, and the same process was used to fabricate the channel for the type I 
device. The fabrication began with transferring the channel pattern on the wafer. A one- 
micrometer thick layer o f positive photoresist (SI 813) was spin coated on the wafer and 
pre-baked on a hot plate at 115° C for 90 s. The wafer was then exposed to the channel 
mask and developed in the MF 319 solution for 60 s followed by a rinse with DI water. 
Next the channel was assembled on the patterned wafer using LBL approach.
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Spin coat positive photo resist 
Expose the wafer to the 
channel m ask 
Develop the exposed wafer 
Perform layer by layer 
self-assem bly 
Use acetone to dissolve the 
photo resist 
Final structure: 
CNTF between the source and 
drain contacts
Figure 11-2: Process flow to assemble the channel in between the source and drain 
for type II device.
For the LBL assembly, polyelectrolyte solutions were prepared by adding 1.4 
wt% of PDDA and 0.3 wt% of PSS in DI water. To improve the ionic strength, 0.5 M 
NaCl was added to the PDDA and PSS solutions. First, a precursor layer was assembled 
by alternately immersing the wafer in the aqueous solution of PDDA and PSS in a 
sequence o f [PDDA (10 minutes) + PSS (10 minutes)] 2. The subscript indicates the 
number of cycles; one cycle includes a 10-minute incubation in the PDDA solution, a 30 
s rinse in DI water, and 20 s air dry followed by a 10-minute incubation in the PSS 
solution, a 30 s rinse in DI water, and 20 s air dry.
The functional reliability of a SWCNT based FET fabricated by LBL assembly is 
much higher if the numbers of assembled layers are more than four [186]. Following the
Oxidized Silicon 
wafer
Gold (Au)
S1813
|  CNTF
| ~ |  Channel m ask
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precursor assembly, the wafer was then alternatively immersed in the aqueous solution of 
PDDA and SWCNTs dispersion in a sequence o f [PDDA (10 minutes) + SWCNTs 
solution (10 minutes)] io. After completing the 10th cycle, the wafer was immersed in an 
acetone bath to lift-off the unwanted CNTF layer and then rinsed with IPA and DI water. 
To improve the current density of the channel, the wafer was annealed at 115° C for 20 
hours in a vacuum. The annealing helps to remove water molecules trapped in the film 
and makes quantum mechanical tunneling easier [174].
The thickness o f the CNTF was measured using a Quartz Crystal Microbalance 
(QCM, USI System, Japan). The precursor layers and the subsequent layers o f SWCNTs 
were assembled on the QCM resonator by following the previously mentioned LBL 
assembly protocol. The relationship between the thickness (d) and frequency shift (AF) 
was given by [187]:
d ( n m ) =  -0 .0 2 2  x AF (Hz).  Eq. 11-1
For the 9-MHz resonator with an effective area o f 0.16 ± 0.01 cm2, the final film 
thickness was ~ 95 nm. The optical micrographs of the devices before and after LBL 
assembly are shown in Figure 11-3. The SEM image of the CNTF with 10 layers is 
shown in Figure 11-4.
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Figure 11-3: a) Optical micrograph of type II device before LBL assembly and b)
optical image o f type II device after LBL assembly. The channel length 
is 100 pm, the width is 150 pm and the channel overlap on the source 
and drain electrode is 20 pm, and the source and drain electrodes are 
made of Au. c) Optical image o f type I device after LBL assembly, the 
source and drain electrodes are made o f Au while the gate electrode is 
made of Al.
Figure 11-4: SEM image o f the CNTF; the CNTF has 10 layers.
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11.4 Passivizing the Source and Drain Contacts
As discussed in Section 9.5.2, the sensing in an immunosensor based on 
individual SWCNT is attributed to Schottky Barrier modulation and Electrostatic gating. 
To eliminate the influence o f contacts during bio sensing, the source and drain contacts 
were passivized. For the type II device, once the channel was assembled between the 
source and drain contacts, a one-micrometer thick layer of SI 813 was spin coated on the 
wafer and then baked at 115° C for 90 s. To open a window that exposes only the 
channel, the same gate mask used for type I device was utilized. After exposing the wafer 
to the gate mask and developing it in MF 319, the wafer was then hard-baked at 115° C 
for 60 s. The schematic cross-sectional view o f the passivized type II device is shown in 
Figure 1 l-5a, the optical graph of the actual passivized type II device is shown in Figure
11-5b.
(ft)
Silicon oxide
Silicon substrate
I l l
Fn channeTi
Source
Electrode
CNTF
Drain
Electrode
Figure 11-5: a) Schematic cross-sectional view of a passivized type II device b)
optical top view image of actual fabricated device (bottom) showing the 
passivized contacts and a window in the middle exposing the microwire 
channel only.
Finally, the wafer was diced into individual devices (~ 2 cm x 2 cm) as shown in 
Figure 1 l-6a, to use them for sensing bio molecules. A PDMS based fluidic channel can 
be incorporated with the device to facilitate the flow o f IgG as shown in Figure 11 -6b.
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Figure 11-6: a) Picture on the top shows an individual device. The size is ~ 2 cm x ~2 
cm b) the device with a fluidic channel and tube connection to facilitate 
IgG flow.
CHAPTER 12
FET BASED BIOSENSOR: EXPERIMENTAL PROTOCOL, 
RESULTS AND DISCUSSION
12.1 Performance of the Device as an FET
Before the device was used as a biosensor to detect biomolecules, it was logical to 
test its performance as a transistor. An FET based on individual SWCNT showed a p- 
type behavior [117] and the same p-type behavior was seen in the FET fabricated by the 
LBL assembly of SWCNTs [186]. As mentioned earlier, the type I device was 
specifically fabricated to verify the FET behavior o f the device. The transfer 
characteristic o f an FET is a plot of drain current (Id) variation in response to the change 
in gate to source voltage (Vgs); for a p-type device the drain current decreases with an 
increase in Vgs. The transfer characteristic of the type I device was plotted by sweeping 
Vgs from -6 V to 6 V and recording the corresponding Id, while maintaining a constant 
drain to source voltage (Vds = 4 V). The output characteristic of the device is shown in 
Figure 12-la. As shown in Figure 12-lb, the drain current started to decrease with the 
increase in the Vgs, and hence, showed a p-type behavior. The majority carriers in a CNT 
are holes. The application of negative gate voltage led to an accumulation o f majority 
carriers in the channel and hence the Id increased. The p-type behavior was consistently
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observed in all the fabricated devices and this reliability can be attributed to the relatively 
large number o f assembled layers.
0 1 2 3 4 5 6 7 8 9  10
Drain Voltage, Yds (V)
x 10
1.5
0.5
Gate Voltage, Vgs (V)
Figure 12-1: a) Output characteristic b) transfer characteristic o f type I device for
drain to source voltage, Vds = 4V. The device gate length is 100 pm and 
gate width is 100 pm.
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12.2 Experiment Protocol
For biosensing experiments, only type II devices were used. To prepare the device 
for the experiments, first the Protein A (PA) and IgG were reconstituted in 0.01 M of 
PBS solution at a pH of 7.4. Next, to immobilize PA on the channel, the device with 
passivized contacts was treated with the EDC solution for 15 minutes at room 
temperature and then rinsed with 0.01 M PBS solution. Following the rinse, the device 
was immediately incubated in 1 mg/mL solution o f PA for two hours at room 
temperature.
The EDC reacts with a carboxyl group on the SWCNT to form an amine-reactive 
O-acylisourea intermediate that spontaneously reacts with primary amines in the PA and 
facilitates the coupling between them. The device was then rinsed with PBS to wash off 
excess PA, followed by a one-hour incubation in the sea block solution prepared by 
adding one part sea block to five parts of 0.01 M PBS. The sea block ensures the 
unoccupied spaces left after PA incubation is not available for further non-specific IgG 
bonding on the channel surface. After incubating the device in the sea block for one-hour, 
the device was rinsed with 0.01 M PBS and blown dry.
All the electrical measurements were performed by applying a Vds -  10 mV and 
recording the drain current in the presence o f the 0.01 M PBS solution. First, the 
reference drain current value (current value without any IgG introduced) was recorded by 
dropping a 10-pL volume of 0.01 M PBS directly on the device. After recording the 
reference current, the device was blown dry and 10-pL volume of the lowest IgG (IgGl) 
concentration was dropped on the device and incubated for 15 minutes, followed by a 
PBS rinse and dry. To record the change in drain current caused by the PA-IgGl
116
interaction, a 10-jj.L volume o f 0.01 M PBS was dropped on the device and the drain 
current was recorded. The 10-pL drop of PBS present on the device was blown dry and 
then alO-pL volume of the next higher concentration of the IgG (IgG2) was added and 
incubated for 15 minutes, followed by another PBS rinse and dry. Again, the change in 
current caused by PA-IgG2 interaction was recorded in the presence o f a 10-pL drop of 
0.01 M PBS solution. After the PBS drop was dried, the device was ready for the next 
higher concentration of IgG. The schematic representation of the experiment protocol is 
shown in Figure 12-2.
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Figure 12-2: Schematic representation of the protocol a) after Protein A
immobilization on CNTF surface b) after blocking unoccupied spaces 
with sea block c) specific bio-affinity interaction between Protein A and 
IgG.
12.3 Performance of the Device as a Biosensor
After incubating the device with PA and then using the sea block to block all the 
other unoccupied areas left after PA incubation, the device was connected to the Keithley 
probe station. As mentioned earlier, a Vds = 10  mV was applied in between the drain and 
the source, and the reference drain current was recorded after dropping 10-p.L of 0.01 M 
PBS solution directly on to the device. As shown in Figure 12-3, the drain current reaches 
an almost steady reference value o f -0.57 pA. The device was then exposed to IgG 
starting with the lowest IgG concentration. A 10-pL volume of 1 pg/mL IgG 
concentration was dropped directly on to the device and allowed to incubate for 15 
minutes. The device was then rinsed with 0.01 M PBS and dried. The interaction between 
PA and IgG is highly specific, where the Fc region of the IgG binds specifically with the 
PA. To record the change in the drain current due to the PA-IgG interaction, a Vds = 10 
mV was applied to the device and a 10-pL volume of 0.01 M PBS solution was dropped
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directly on to the device. The IgG was reconstituted in 0.01 M PBS at pH 7.4, and at this 
pH the measured zeta potential o f the IgG was around -11 mV. The specific binding 
between PA-IgG on the surface o f the channel in the presence of a 0.01 M PBS droplet 
was then equivalent to applying a negative voltage to the channel. Based on the transfer 
characteristics o f the type I device as shown in Figure 12-1, the drain current will 
increase with increasing values o f negative gate voltages. For the type II device exposed 
to the lowest IgG concentration (~lpg/mL), the drain current also increased by ~ 300 nA. 
Further exposure to higher concentrations of IgG showed a consistent increase in the 
drain current value.
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Figure 12-3: Drain current variation in response to various IgG concentrations.
The average value of the drain current for different concentration of IgG is shown 
in Figure 12-4. The absence of a gate bias for type II device means it operates closer to 
the threshold voltage (V t =  0 V ) where the relationship between the drain current and the 
applied gate voltage is non-linear. The initial reference current (current in presence of 
PBS only) is for a device without an applied gate voltage. The change in the drain current
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after the addition o f lpg/mL of IgG is -300 nA, (Figure 12-3). This can be attributed to 
the fact that the addition o f IgG shifts the operating point into the non-linear region, 
which causes a big change in drain current. The change in the drain current after the 
addition o f 100 pg/mL of IgG is -  45 nA. The change in the drain current after the 
addition o f 1 ng/mL is -  95 nA, and the change in the drain current after the addition of 
200 ng/mL is -115 nA. Further addition of IgG (1 pg/mL) changes the drain current by 
only -  80 nA. Once all the available Protein A on the substrate interacts with the added 
IgG, the change in current is expected to drop which is what we observed when IgG (1 
pg/mL) is added.
1,200 
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Figure 12-4: Average drain current values for different concentrations o f IgG (three 
devices were used during the experiment).
CHAPTER 13
FET BASED BIOSENSOR: CONCLUSIONS AND FUTURE WORK
13.1 Conclusions
To avoid the complications encountered in the fabrication o f biosensors based on 
a single CNT, the biosensor was fabricated out o f carbon nanotube thin film. The FET 
based biosensor was fabricated using a combination of photolithography and Layer-by- 
Layer self-assembly. Device characterization confirmed that the fabricated device 
behaves like a p-type transistor. Experiments done to investigate the response o f the 
device to Protein A-IgG interaction indicated that the device could detect IgG 
concentrations that are as low as 1 pg/mL.
13.2 Future Work
The response o f the device could be improved by avoiding the acid treatment 
done on the CNTs. This treatment helped to disperse CNTs in water, but it does affect the 
electrical properties of the tubes. The device offers a platform to design sensors for 
detecting cancer markers
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